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ABSTRACT 
A great advance in our understanding of antibody 
structure and function comes from a recent technology which allows 
the genetic reconstruction of the antibody combining site as a single-
chain Fv (scFv) fragment. The scFv fragment is often borne on the 
coat protein of a filamentous bacteriophage or expressed on its own as 
a soluble protein. Whereas the conventional combining site is formed 
by the association of the variable regions (VH and VL) of two separate 
polypeptide chains, the scFv fragment is composed of only the Vh and 
Vl segments joined together by a synthetic linker. A flexible linker is 
used which presumably allows the Vh and Vl segments to associate 
together just as in the conventional antibody molecule to form a 
pocket or groove as the active site. Many studies indirectly attest to 
the formation of such a site because scFv proteins with the expected 
specificities were obtained. I report, however, that the combining site 
of scFv proteins may not be exactly the same as that of conventional 
antibodies. I can say this only because I am able to compare the two 
forms of an antibody in which the conventional protein, unlike those 
used in similar studies previously, exhibits an unusual specificity. 
This hybridoma-derived antibody, Mab2，recognizes both the 
immunodominant epitope (phosphorylcholine [PC]) and carrier 
residues of the immunizing antigen (derived from Trichinella 
spiralis). Transforming the hybridoma antibody to an scFv protein 
resulted in the loss of carrier specificity but not binding to the PC 
epitope. This finding, together with the observations that free PC did 
not affect the binding activity of the scFv protein, suggest that the 
scFv combining site may be very loosely structured so that a defined 
pocket may not exist prior to antigen encounter. 
ii 
The original objective of my study was to see whether 
certain residues, notably, glycine at 49H and serine at 40H were 
responsible for the carrier specificity of Mab2. I intended to change 
these to "wild type" residues to see if the carrier specificity would be 
destroyed. In carrying out the site-directed mutagenesis experiment, I 
decided to first transform the hybridoma antibody into an scFv 
fragment because it is easier to work with this smaller and simpler 
protein. I was successful in making the scFv fragment although, 
because the technology involved is relatively new, I had encountered 
various technical problems. Because the scFv derivative of Mab2 is 
already no longer carrier-specific like the original antibody, the 
contribution of glycines (H49) and serine (H40) to the carrier 
specificity of the original antibody cannot be addressed in the scFv 
model. 
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摘要 
近年發展的科故加強了我們對抗體結構及功用之認識。利 






本給文以一雜文細胞產生之單克陵抗體 ( M a b 2 )作單鏠可變 
序段轉化，發貴單鏠可變片投與抗體丙的結合部位並非免全相 







位結構與抗栽體活性的關係。逄過改變重鏠上40位的 se r ine及49 
位的g l y c i n e遑兩彻獨特的妻基政至與生破種系相同，從而觀泰 
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CHAPTER 1 INTRODUCTION 
1.1 ANTIBODY STRUCTURE AND DIVERSITY 
Antibodies are made in all vertebrates as part of the immune 
response to antigenic challenge by foreign substances. They play a 
key role in the adaptive immune response as highly specific and 
highly specialized proteins in recognizing and dealing with foreign 
antigens. Following binding to the antigen, the antibody activates 
complement leading to inflammatory reactions or promotes 
phagocytosis by neutrophils and mononuclear phagocytes, leading to 
eventual degradation and removal of the antigen. If the antigen is a 
bacterium, this will be killed. B cells recognize foreign antigens 
through the immunoglobulin (Ig) receptor on their surface. Antigen 
binding to the Ig receptor together with helper T cells interacting with 
the peptide-MHC complex also on the surface of the B cell，result in 
activation of the cell causing it to proliferate and differentiate. The 
ultimately differentiated cell is the plasma cell which secretes 
antibodies of the same specificity as that of the membrane Ig. Some 
of the differentiated cells can undergo heavy-chain isotype switching 
and affinity maturation to secrete high-affinity antibodies of classes 
other than IgM, such as IgG or IgA. Some of the progeny cells will 
become long-lived memory cells. 
Antibodies can directly neutralize the deleterious effects of 
the antigen, which may be of this is a toxin, drug or a virus. They also 
activate the complement system, a family of heat-labile serum 
proteins, leading to inflammatory reactions in local tissue and lysis of 
certain cell targets. These antibodies can also function by 
opsonization, which promotes phagocytosis through Fey receptors on 
1 
neutrophils and mononuclear phagocytes, leading to eventual 
degradation and removal of the antigen. 
The repertoire of antibodies that can be produced in a person 
is impressive, which has been estimated to be as many as 10 million 
different specificities in the primary response, and this may be further 
expanded by several orders of magnitude in the secondary response 
through the effects of somatic mutation (French et ah, 1989; 
Perlmutter et al., 1984). As a result of somatic mutation, the 
secondary antibody response has remarkable maturation in both the 
affinity and specificity. Study on the location and nature of these 
mutations can provide a better understanding of the stmcture-and-
function relationship of the antibody molecules. 
Antibodies are conventionally multivalent molecules 
comprising a light (L) chain of approximately 220 amino acids in 
length and a heavy (H) chain composed of 450-575 amino acids 
(Fig.l). The L chain contains two Ig domains: the N-terminal domain 
(Vl), which is variable, i.e., it varies in composition from antibody to 
antibody, and the C-terminal domain (CJ, which is constant, i.e., it is 
the same for all L chains of the same type. The H chain is also made 
up of an N-terminal variable domain (V^ and three or four constant 
domains (CH). The antibody fragment formed by VL and VH is the 
smallest active unit in the antibody called Fv. A slightly bigger 
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Figure 1 Antibody structure: alpha-carbon trace of a model oflgGl. From 
RJDavies (1990) 
The various domains of the light and heavy chains are labeled. 
The antigen binding fragment. Fab, consists of V^, ChI and V。， 
The constant region, Fc, consists of and 
3 
\ 
Association of the H and L chains involves both covalent 
and non-covalent interactions. Covalent interactions are in the form 
of disulfide bonds between two cysteines residues present in the 
carboxy terminus of the L chain and the ChI domain. Non-covalent 
interactions arise primarily from hydrophobic interactions between Vl 
and Vh residues and between the Cl and the C y residues. The 
association of the VL and VH domains produces a spatial apposition 
such that both the juxtaposed V domains can each contribute to the 
binding of the antigen. 
Within the V region of both H and L chains several highly 
divergent stretches of amino acid sequences are present. These are the 
hypervariable regions (also known as complementarily determining 
regions or CDRs), and they are held in place by more conserved 
framework regions (FRs). In an intact Ig, the three CDRs of a L chain 
and the three CDRs of a H chain are brought together to form the 
antibody combining site, and these regions interact directly with the 
antigen. The CDRs are so-called because they form a surface 
complementary to that of the bound antigen. 
Differences in H and L chain pairing as well as differences 
in the primary and secondary structures of the CDRs generate the 
great diversity in antibody specificities. To understand how the 
different H and L chains, including the different CDRs are generated, 
we need to understand how the Ig genes work. 
4 
1.2 ANTIBODY GENES 
Since the primary antibody repertoire is at least 10^  
specificities, this would require one-third of the human genome to 
code for these proteins. This has puzzled immunologists a long time 
but the breakthrough came with the idea that the Ig genes are 
composed of several mini-genes (Hilschmann and Craig, 1965) and 
these are recombined to form an active gene (Dreyer and Bennett, 
1965). Thus, Sussumu Tonegawa showed that the size of the Ig gene 
isolated from an antibody-producing tumor (myeloma), is markedly 
smaller than that of the corresponding germline Ig gene. This 
suggests a process of recombination or rearrangement of the germline 
genes during B cell ontogeny. 
The organisation of Ig genes in the germline is 
fundamentally similar in all species of animals studied. Genes 
encoding the two L chains, K and 入，and the single locus containing 
the various H chain genes are located on different chromosomes. In 
the mouse, the H chain locus is located in chromosome 12 while the K 
and X loci are located on chromosome 6 and 16, respectively (Fig.2). 
Each H and L chain locus is composed of the V- and C- region genes, 
which are separated from each other by long stretches of non-coding 
DNA. At the 5' end of each locus are the V region exons; the first 
exon contains a leader sequence which encodes a signal peptide which 
guides the post-translation modification and trafficking of the Ig 
polypeptide. The number of murine V genes varies from 2 for X, 
about 250 for K, to about 1000 for the H chain. Downstream from the 
V genes and separated by introns are additional coding sequences 
which make up the joining (J) segments. There are 4 J^ segments, 5 
JK and 2 J人.Additionally in the H chain locus, there is also the 
diversity (D) segments separating the V and J genes. There are 12 D 
5 
genes. Downstream from the VDJ or VJ genes are the C region genes. 
The K L chain locus has a single C gene, \ has 3 to 6 , while the Ch 
genes of different isotype are arranged in tandem in the following 
order: 5，yl, y3, y2a, y2b, s and a. Each Ch genes is composed of 3-
4 exons. 
During the development of B cell, the first rearrangement 
involves the H chain locus involving the joining of one randomly-
selected D gene to one randomly-selected J genes and the deletion of 
the intervening DNA (Fig.3). Following this rearrangement, one of 
the many V genes is joined to the DJ complex, giving rise to a 
rearranged VDJ. The rearranged gene is active, and transcription 
proceeds from the promoter at a site 5' to Vh，to all the way down to C 
genes. Subsequent processing of the RNA leads to splicing out of the 
intron in between the V-D-J complex and the most proximal C gene, 
which is Cp, in the primary response. This gives rise to a functional 
mRNA for the |i chain. 
The next rearrangement involves one of the L chain loci 
which is similar to that of the H chain (Fig.4). One V segment is 
joined to one J segment, forming a VJ complex. Primary transcript 
contains the VJ complex and the C region separated by an intron. 
This intron is then spliced out to give a processed transcript for 
translation. The random combination of V-J segments generates 
diversity for the antibody repertoire. 
In addition to the random assembly of the V, D and J genes 
in the H locus and the V and J genes in the L locus, the imprecision in 
joining at the V-D-J junctions, results in the addition or deletion of up 
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(DNA rearrangement) : D - J joining 
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5’ • • • • • [ Z Z H Z Z h 3. 
/ L � 
R e a r r a n a e d Somatic recombination 
D N A ， r (DNA rearrangement): V-D-J joining 
L1 V1 D2 J1 J2-4 C ^ C5 
5’ H h M i i H ~ r ~ " H h 3. 
Transcription . 
T 
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Processing, glycosylation of protein 
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V c 
M. h e a v y c h a i n ^ ^ • B C j U Z D 
Figure 3 Sequence of gene rearrangment, transcription, and synthesis of the 
mouse immunoglobulin |j. heavy chain. From Abbas (1994). 
In this example, the V region of the jj, chain is encoded by the 
exons VI，D2，and JI. V genes are indicated as VI to Vn. 
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L1 V1 Ln Vn J1-4 Ck 
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Figure 4 Sequence of gene rearrangment, transcription, and synthesis of the 
mouse immunoglobulin K light chain. From Abbas (1994). 
In this example, the V region of the K chain is encoded by the 
exons VI and Jl. V genes are indicated as VI to Vn. 
9 
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The V genes of both the H and L chains encode the amino acid 
sequences in CDR 1 and CDR 2，while CDR 3 sequences are encoded 
by VJ or VDJ genes. The rearranged Ig genes are uniquely subjected 
to hypermutation, in which somatic point mutations occur at a rate of 
10-3 per V gene base pair per cell division, that is 10^  to 10^  times 
higher than the spontaneous rate of mutation (Neuberger and Milstein, 
1995; Steele et al., 1997). B cells expressing antibodies that have 
acquired higher affinities due to the mutations will be selected by 
antigen and stimulated to proliferate and differentiate to produce 
antibody. 
1.3 THE ANTIBODY RESPONSE TO 
PHOSPHORYLCHOLINE 
CH3 
CH3 一 N^ 一 CH2 一 CH2 一 P O / 
I 
CH3 
Phosphorylcholine (PC) is a small hapten, with a maximum 
dimension of about 8A, and containing the trimethyl-stmcture of 
choline and the negatively charged phosphate (see diagram above). It 
is found ubiquitously in nature for example in microorganisms such as 
Streptococcus pneumoniae and Trichinella spiralis. Since PC is 
simple and well-defined, and monoclonal antibodies with anti-PC 
activity have been available since 1972 (Potter, 1971), PC has been 
used most widely as a model antigen to study the immune response 
and to evaluate the structure of the antibody combining site. 
1 0 
The murine antibody response to PC has been well studied 
and is reviewed by Perlmutter (Perlmutter et al., 1984). Two major 
groups of anti-PC antibodies are expressed which differ in fine 
specificity, idiotypic (Id) expression and isotype preference. Group I 
antibodies react predominantly with the PC moiety itself, display 
mostly the T15 Id and, usually belong to IgM, IgA, or IgG3. On the 
other hand, Group II antibodies recognize the PC hapten in 
conjunction with the azophenyl spacer which links the hapten to the 
carrier, are T15 Id； and belong to the IgGl，IgG2a, IgG2b isotypes 
(Chang et al, 1982). Whether group I or group II antibodies are 
produced depends on the stage of the immune response and the type of 
PC antigen used in the immunisation. Antigens which are thymus-
independent, such as the pneumococcal capsular antigen, 
Pneumovax(R)23 (PnX), can induce only group I antibodies in the 
primary and secondary responses. On the other hand, thymus 
dependent antigens, such as PC conjugates of keyhole limpet 
hemocyanin (KLH), bovine serum albumin (BSA) or ovalbumin 
(OVA), induce group I antibodies in the primary response but both 
group I and group II antibodies in the secondary response. 
1.3.1 Group I antibodies 
The group I anti-PC antibodies belong to three related 
families of antibodies, T15, M167 or M511, and M603. In the 
primary response in BALB/c mice, the T15 Id+ antibodies dominate, 
accounting for 90% of the antibody population, with M603+ and 
M 5 i r antibodies accounting for the rest. Molecular analysis of the 
group I antibodies showed that they all utilise VHI, JHI and D F L I 6 . I 
gene (Table 1). The L chain is different for the different families: 
V H 1 - V K 8 ( M 6 0 3 + ) , V H 1 - V K 2 2 ( T 1 5 + ) a n d V H 1 - V K 2 4 ( M 5 1 1 + ) . 
11 
Analysis of the heavy chain sequences showed that somatic mutations 
and N region additions or deletions of nucleotides at the V-D-J 
junction is essential for M603+ and M 5 i r antibodies to bind PC 
(Feeney et al., 1988). In the fetal or neonatal mouse, there is no N-
region addition or deletion and the V-D-J junctions are rather 
conserved. This early Ig gene structure may persist in the adult 
through the long-lived B cells (Feeney, 1990; Feeney, 1992). 
Moreover, the germline encoded M 5 i r and M603+ antibodies have 
relatively lower affinities than those of the germline encoded T15+ 
antibodies. Thus, T15+ antibodies have high affinities even without 
N-region modification and are preferentially selected by antigen. This 
explains why in BALB/c mice T15+ antibodies dominate the primary 
anti-PC antibody response. (Feeney et al., 1988; Feeney and Thuerauf, 
1989). However, M603+ and M511+ antibodies are more vulnerable to 
somatic hypermutation than T15+ antibodies and thus have a greater 
chance for affinity maturation (Chen et al., 1995; Feeney et al., 1988). 
After the late primary response, the M603+ and M 5 i r antibodies 
dominated the subsequent responses. 
Interestingly, the secondary response, M603+ antibodies are 
perferentially induced by Proteus morganii while M511+ antibodies 
are selected by Ascaris Suum (Claflin et al., 1985). Obviously, the 


































































































































































































































































































































































































































































































































































































































































































































































































1.3.2 Group II antibodies 
Group II antibodies are usually produced during the 
secondary response and show greater specificity for a derivative of PC 
(nitrophenylphosphorylcholine, NPPC) than PC itself. Group I 
antibodies behave in the opposite way. Molecular analysis of group II 
antibodies revealed an unusual usage of Ig genes, different from those 
of group 1. Group II antibodies are in fact expressed independently of 
group I antibodies. (Heusser et al., 1984). 
1.3.3 Fine specificity of group I antibodies 
The group I antibodies can be distinguished from one 
another based on the inhibition efficiency of PC and its analogues on 
the binding of these antibodies to PC-OVA. The analogues are: 
choline (©), glycero-phosphorylcholine (GPC) and phosphonocholine 
(pC) (Leon and Young, 1971). The results are shown in Table 2. 
Table 2 Efficiency of inhibition by PC and its analogues on the binding of 
antibody to PC-OVA. 
Inhibition pattern family 
GPC>PC>©>pC M167/M511 
P C > G P C = p C » © M 6 0 3 
PC>GPC>pC»© tT5 
The L chain used in the different families, together with the 
somatic mutations in the various CDRs，presumably influence the 
binding of the antibodies to PC and its analogues. All three families 
of antibodies react with the trimethyl-choline, and interact with the 
positively-charged phosphate group which enhances the binding. 
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Interaction of the glycero-group in GPC with the carrier-determining 
regions of M167/M511 further enhances the binding. 
1.4 ANTI-PHOSPHORYLCHOLINE ANTIBODY 
STRUCTURE 
The complete three-dimensional structure of M603 has been 
determined and refined to 2.7人 by X-ray crystallography (Fig.5) 
(Satow et al, 1986; Segal et al, 1974). At pH 7，PC has 2 negative 
charges in the phosphate group and 1 positive charge on the 
quaternary nitrogen of the choline. The 6 CDRs of the antibody form 
an antigen-binding pocket (Potter et al., 1977). PC occupies only a 
small part of this cavity. PC sits deep inside the pocket, with the 
choline group down at the bottom and the phosphate group towards 
the exterior. PC is bound asymmetrically, being closer to the H chain 
than to the L chain (Fig.6). From the top view, the CDRs are arranged 
in a clockwise pattern, starting from 12 o'clock: CDR3(H), CDRl(H), 
CDR2(H), CDR3(L), CDRl(L) and CDR2(L). The 3 CDRs of Vh 
together with the CDR3 and CDRl of VL form the PC-binding pocket. 
CDR2(L) is shield from binding to PC by the long open loop of 
CDRl(L). 
In the H chain, Tyr33 (CDRl) forms a hydrogen bond with 
the phosphate group of the PC hapten (Fig.Ta). Glu35 interacts 
electrostatically with the choline group. In CDR2, Arg52 and Glu58 
interacts electrostatically with the phosphate group and choline group, 
respectively (Fig.7b). CDR3(H) is located at the tip of a long hairpin 
loop; it is the most variable of the CDRs (Fig.Tc). Only one side-
chain from CDR3(H), TrplOOc, interacts with the hapten in the case of 
the T15+ and M603+ proteins. The M167+ protein contains amino 
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acids with bulky side-chains as tryptophan may conserve this function. 
CDR3(H) varies in length and this probably affects the size of the loop 
and the interactions with Vl. The Tyr98, SerlOO, ThrlOOa and 
TyrlOOd，or conservative replacements of these in the CDR3(H), can 
1 
form hydrogen bonds Ser, Asx, and Glxs in CDRl(L). The presence 
of additional residues such as Ala96 and Asp97 found in the Ml67+ 
protein, can stabilise the conformation by extending the helical region 
at the bend into the solvent, by forming hydrogen-bonds with 
CDRl(L) residues. 
In the L chain, CDRl apparently does not interact with the 
PC part of the antigen (Fig.8a,b). The long bending portion of 
CDR1(L) in M603 allows close contact with the side-chains of 
residues in CDR3(H), and fills up potential space between CDR3(H) 
and CDR2(L). The long amino-terminal stretch of CDRl(L), which 
projects into solvent, probably plays a more direct role in antigen 
carrier interaction. In the repeating unit in the pneumococcal C 
polysaccharide antigen (with which M603 interacts), the presence of � 
sugars in the repeating unit provides many OH groups for hydrogen 
bonding with such side-chains as serine, threonine and tyrosine which 
are present in CDRl(L). In CDR3(L), the antigen-binding surface is 
confined to the bend portion of the loop (Fig.Sc); this contributes to 
the binding pocket and binds to PC. Hydrogen-bonds are formed 
between Asp97L and Asn95H, and between TrylOOL and Glu35H 
which contribute to the architecture of the innermost portion of the 
combining site. These two L chain residues, together with TrplOOcH 
and Tyr33H, interact with the methyl side-chains of the 
trimethylammonium group in PC by Van der Waal's. The methyl 
group in Leul02L also associate with the amide group in Asn95H by 
Van der Waal's force (Fig.9). 
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_ _ . 
Figure 5 Three dimensional structure of the phosphorylcholine specific 
antibody (PcPC603) skeleton obtained from X-ray ciystallography. 
Satow, 1986. 
Continuous lines denote the heavy chain. The filled circles shows 


















































































































































































































































































































S03I GUY PHE THR PHE SS* ASP PHE TYR MET - GLU TRP 
T I S G L Y PHE TKR PHE S E » ASP PHE TYR M E T - GLU IRP 
G L Y PHE THH PHE SEB ASX PHE TYR M E T - GLU TRP 
(b) . 
5。 63 
605 ALA SER ARG ASM LTS GLY ASM LYS TYR TMR TM« GLU TYR Sen 
T15 ALA SER A»G ASN LYS ALA ASH ASP TYR TMR THR GLU TYR SEA 
M167 ALA SER ARG Sett LYS ALA HIS AS? TYR ARG THH GLU "VH Sea 
(c) , 
- ^ 107 
96 . 107 
603 Crs ALA ARG ASM TYR - TYR GCY SER TH« - - TRP TY« PHE 
T15 CYS ALA AAC ASP TYR - TTR GLY SER SER TYR - . TRP TYR ？ -
M157 CYS THR ARG ASP ALA ASP TYR GLY (ASP) SEA TYR PHE SLY TYR PHE 
Figure 7 Interaction of heavy chain CDR residues with phosphorylcholine. 
The interactive amino acids are shown as (a) CDR1(H): Tyr(33). 
G1U(35); (b) C D R 2 ( H ) : Arg(52), Glu(61); (c) C D R 3 ( H ) : Tyr(104),-
Ser(106), Thr (107)，Trp(109). Numbering of amino acid 






. / � < 
Figure 8 Micro-structure of light chain CDR and the interaction with heavy 
chain. 
(a) CDRl(L) filled into the space of CDR3(H) and CDR2(L). (b) 
CDR2(L) and (c) CDR3. 
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S w , 
Figure 9 Hydrogen-bonds from part of the combining site residues of 
McPC603. From Satow etal, 1985 
Phosphate group is indicated by thick lines and the 2 larger circle/ 
represent the choline. Residues F38 and D97 to LI02 are light 
chain amino acids, the remaining residues being from the heavy 
chain. Pototial hydrogen bonds are illustrated with thin 
continuous lines. 
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1.5 RECOMBINANT ANTIBODY 
The specificity of an antibody is obviously determined by 
the structure of the combining site of the molecule, i.e., the Fv region. 
This depends on what kind of V^ and VL protein segments are used. 
These segments are encoded by V-D-J genes for VH and Vj genes for 
VL. 
There are 2 ways of studying how the structure of the 
combining site determines the specificity of the antibody. Firstly, 
different naturally-occuring antibodies isolated from myelomas or by 
hybridoma technology which have defined specificities are examined 
to see what polypeptide chains are used. Secondly, site-specific 
mutations are introduced at the gene level to well-characterised 
antibodies to see the effect on the binding specificity. This latter 
approach is becoming very popular and powerful today. This is aided 
by recent advances in recombinant DNA technology and by our vast 
knowledge of the Ig genes (see section 1.2). 
Whole antibody molecules can be produced by expressing 
reconstructed Ig genes in mammalian cells such as the myeloma lines, 
SP2/0, YB/0 and NSO, or in SV-40 transformed monkey kidney cells 
(COS). Usually, the Ig genes of the H and L chain are cloned into an 
expression vector which contains a selectable marker gene such as 
adenosine deaminase (ADA) or neomycin (Neo) to allow for positive 
selection of tranformed clones. Both chains are expressed under the 
control of Ig gene promotors and enhancers. After appropriate post-
translation possessing including giycosyiation and folding of both 
chains, the recombinant antibodies are secreted to the culture 
supernatant. The yield of antibody varies from 0.1 mg ml] to lOmg 
ml-i，which is usually less than that obtainable from hybridomas. 
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Recently, since 1988, it has become possible to produce 
antibodies in bacteria (Skerra and Pluckthun, 1988). The bacterial 
system has advantages over the mammalian system. Rapid generation 
time and easy selection with results obtainable within a week make 
the cloning easier. Also, the high level of induction of the desired 
protein which can reach up to 30% of total bacterial proteins allows a 
yield of 10 times or more higher than that obtainable by mammalian 
expression. However, due to the limitation of the bacterial system, 
antibodies cannot be expressed as whole Ig but as small active units in 
the form of，for example, single-chain variable fragment (scFv). In 
this form, the VH and VL segments are linked together by a short 
polypeptide linker. This linker is usually made up of a series of 
glycine residues to provide a flexibility and water-solubility of the 
molecule, and for proper folding and association of the domains. 
Proper folding of the two variable domains involves the use of 
disulfide bonds and a conductive environment. Thus, a bacterial 
signal peptide is genetically fused to the N-terminal of scFv, which 
directs the recombinant scFv to the periplasm of the bacterial cell 
(Andersson and von Heijne, 1991). The oxidizing environment in the 
periplasm permits proper disulfide bond formation in the Ig. By 
fusing the C-terminal of scFv to a bacteriophage coat protein (see next 
section), the scFv can be expressed as phage-displayed antibody 
fragment. By incorporating an amber stop codon to the expression 
phagemid vector between the scFv and phage (pIII) genes, soluble 
scFv proteins free from the phage can be obtained in appropriate non-
suppressor Escherichia coli hosts. 
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1.5.1 PHAGE BIOLOGY 
Before I discuss further the technology of making phage-
displayed antibodies fragments, it is pertinent to understand the 
biology of the bacteriophage used as the vector. M13 phage, together 
with f l and fd, are collectively called filamentous or Ff phage because 
of their filamentous appearance (Fig.lO & 11) (Rodi and Makowski, 
1999). These viruses depend on their F-pilus to infect the E.coli. The 
long (900mn) and narrow (7nm) Ff virion has a single-stranded (ss) 
DNA genome and a major coat protein (pVIII) all round the body of 
the phage, and at a polar and, several minor coat proteins, including 
pIII. There are 2700 copies of pVIII and 4-5 copies minor coat 
proteins, including pIIL 
As shown in Fig. 12 , infection begins when the pIII protein 
of the phage adsorbs to the tip of the F-pilus of a host cell (Vieira and 
Messing, ； Wang et al., 1995). With the virion thus brought to the 
bacterial cell surface, the viral ssDNA, the (+) strand, is injected into 
the cytoplasm of the cell. DNA polymerases of host origin employ 
the (+) strand as a template to synthesise a complementary (-) strand, 
ultimately yielding a double-stranded or RF (replicative form) phage 
genome. Synthesis of the (-) strand begins at the origin of the viral 
genome, ori(-), one of several sites within the intergenic region (IR). 
Because of the double-stranded nature of two adjacent stem loops, 
oii(-) resembles the -35 and -10 regions of RNA promoters; this is 
important for primer synthesis by RNA polymerases. Following (-) 
strand synthesis, host-mediated processes lead to the production of 
coat proteins (pIII, pVI, pVII，pVIII, pIX), proteins involved in phage 
assembly and export (pi and pIV), as well as proteins necessary for 
phage replication (pll, pV, pX). The synthesis of the various phage 
proteins is achieved with little apparent feedback control. 
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Phage replication is initiated by the pll protein, which nicks 
the (+) strand at ori(+) in the intergenic region, allowing the free 3’ 
end to serve as a primer for rolling circle replication on the (-) strand 
template. After the newly synthesised (+) strand is completed, pll 
ligates the molecular ends to form a closed circle. Further formation 
of the ss-stranded DNA is arrested by the increasing levels of the 
ssDNA-binding protein, pV. All five coat proteins are synthesised 
and inserted into the inner membrane. The N-terminal signal peptides 
are cleaved upon membrane insertion, with the C-terminal 
hydrophobic regions anchored in the membrane and their N-termini in 
the periplasm. The initiation of assembly and export involves 
interactions among a packaging signal within the intergenic region, 
the formation of gated pI-pIV multimeric export channel spanning the 
inner and outer membranes, host thioredoxin, and minor coat proteins 
pVII and pIX. The assembly process involves ATP hydrolysis and 
proton motive force, and pV on the stabilised ss DNA is replaced by 
PVIII. Finally, pVI and pIII are added to the end of an extruding 
virion to complete the packaging process. 
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Figure 10 The appearance of Ml 3 phage under electronic microscope. 
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7nm 
^ f f i pVII, pIX: 4 or 5 copies 
L 二 
genome length) 
^ ^ p V I : 4 or 5 copies 
^ COCO pin: 4 or 5 copies 
^ ^ ^ ^ Encoding gene and > 
affinity selected scFv 
Figure 11 
Upper panel: Cartoon illustrates inherent simplicity of virion 
structure: a single stranded circular genome is surrounded by 
� 2 7 0 0 copies of the major coat protein pVIII and 4 or 5 copies 
of each of four species of minor coat protein, including pIII 
which binds to the host cell F-pilus. , 
Lower panel: The key feature of phage display scFv is that an 
affinity-selectable combination of VH and VL fragment and its 
encoding DNA are packaged together. (Figure adopted from 
Brett Finay review) 
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Figure 12 The infection cycle of Ff filamentous phages. 
The drawing is highly schematic. For the mature virion, the 
stoichiometry for the minor protein pIII is approximately correct, 
but the copy number of pVm (around 2,700) is greatly under-
represented. The single-stranded circular DNA genome (in both 
incoming infecting and outgoing progeny virions) and the dsDNA 
RF form are highlighted in the figure. 
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1.5.2 Phage-displayed antibodies 
Various recombinant proteins have been expressed in Pf 
phage as a fusion protein of the coat protein. Early examples are 
human growth hormone (Bass et al., 1990) and single-chain Fv 
(McCafferty et al., 1990) and Fab antibodies (Barbas et al, 1991; 
Kang et al., 1991). Phage-display technology is becoming very 
important in protein engineering and has the following advantages: (1) 
Large libraries of the recombinant protein with sufficient diversity can 
be generated. Thus, more than 10 million different Ig cjones, in the 
same order as the mouse primary antibody repertoire, can be 
generated by random combinatorial assembly of mouse Ig H and L 
chain genes. (2) The single stranded genome of the phage serves as a 
good template for targeted mutagenesis for protein engineering study. 
(3) The small copy number (five) of the structural coat protein pIII 
allows easy enrichment and screening. (4) Importantly, affinity 
selection of the target protein displayed on the surface of the phage 
particle can be easily carried out. 
pin is required not only for F-pilus adsorption but also for 
terminating viron assembly and stabilising the viral particle. In 
electron micrographs, pIII is seen to have a knob-on-stem appearance, 
implying that it has two functional domains. The N-terminal two-
thirds of the molecule mediates virion adsorption while C-terminal 
one-third functions in virion assembly and structure. Modifying pIII 
in the form of a fusion protein may delay the expression of pIII; this 
can lead to the production of viral particles containing two or more 
unit-length phage genomes. The fusion protein also hindered pIII 
from adsorbing to the F-pilus, thus making the phage less infective. 
Fusion proteins borne on pVIII cause steric problems in pVIII-pVIII 
interactions which affects the assembly process. Moreover, the 
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increased size of the fusion protein may restrict the export of pVIII 
through the pI-pIV channel. 
Available commerically today are various expression vectors 
which allow scFv fragments to be made as phage-displayed proteins 
or as soluble products. One such system, which is used in this study, 
is the Recombinant Phage Antibody System developed by Amersham 
Pharmacia Biotech, Uppsala, Sweden. The map of the phagemid 
vector, called pCANTAB 5E，is shown in Fig.l3. All the information 
. required for the production of scFv proteins including the packaging 
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Figure 13 The pCANTAB-5E phage-display vector. 
DNA 
insert for VH-1 inker-VL gene was cloned in between the 
pin(g3) signal and the E-tag polyepetide gene hy Sfi 1 and Not I 
enzyme sites. The vector contain a M13 ori for replication which 
can express scFv as a soluble protein by the amber stop codon in 
non-supressor E.coli strain or as phage-displayed scFv by forming 
a fusion protein with the pIII (gene 3). 
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1.5.3 Helper phage 
The M13K07 helper phage is an Ml3 phage which has gene 
II derived from M13mpl, the origin of replication from pl5A and the 
kanamycin-resistance gene from Tn 903 (Fig. 14a). Using the pl5A 
origin, the phage is able to replicate independently of gIL The 
insertion of both the pl5A origin and the kanamycin-resistance gene 
into the phage origin of replication creating an origin that is less 
efficient for the functioning of the mpl gll than the wild-type present 
in the plasmid. This, plus the higher copy number of the plasmid, 
leads to the preferential packaging of the plasmid DNA into the viral 
particles. However, the mpl gllp functions well enough when 
M13K07 is grown by itself, leading to high production of phage 
particles. 
The intergenic region structure (Fig. 14b) contains regions 
important for four phage processes: (1) The sequences necessary for 
the recognition of ssDNA phagemid by phage proteins for its efficient 
packaging into viral particles; (2) the site of synthesis of an RNA 
primer that is used to initiate (-) strand synthesis; (3) the initiation and 
(4) termination of (+) strand synthesis. The most important element 
for the ftmction of M13K07 is the origin of replication of the (+) 
strand. This is a 140 bp sequence divided into two domains. Domain 
A, about 40 bp, is essential for replication and contains the recognition 
site for gll to create the nick that initiates and terminates replication of 
the RF. Domain B is about 100 bp long and acts as an enhancer for 
gll to function at domain A. 
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Figure 14 Helper phage M13K07. 
(a) M13K07 vector contains all the M13 essential gene for 
structural protein and assemble signals, in addition with the 
kanamycin resistance gene (Km). 
(b) The intergenic region of Ml 3. Potential secondaiy structure is 
represented by hairpin structure a-e. 
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1.6 OBJECTIVES AND SCOPE OF STUDY 
The aim of my study is to see whether the fine specificity of 
an antibody is determined by specific residues in the active site of the 
molecule. A PC-binding IgGl antibody, Mab2, produced by a 
hybridoma derived from a BALB/c mouse which had been immunized 
against Trichinella spiralis, was previously found to exhibit a unique 
carrier specificity (Lim et al., 1994). This antibody was found to bind 
to the immunizing antigen (TsAg) but not to other PC-associated 
antigens such as pneumococcal antigen (PnVax) and PC-conjugated 
ovalbumin (PC-OVA). Sequence analysis of the protein revealed the 
presence of a V^ polypeptide which was very similar to that of the 
M511 myeloma protein except for four amino acids, while VL was 
completely identical to that of the Ml67 myeloma protein (Table 1). 
Several M511/M167+ proteins, including the prototypic M511 protein 
and PC-binding proteins of other families (TEPC 15 and W3207), 
when examined in parallel, were found to be largely indiscriminate 
although minor, subtle differences were observed among some of the 
antibodies. Thus, unlike Mab2, these other antibodies are not carrier-
specific and recognize the PC hapten as if this is the complete antigen. 
A comparison of the V^ sequences of Mab2 and these 
proteins revealed that of the differences seen, the single most 
important substitution in Mab2 which could contribute to the unique 
specificity of the molecule is the glycine residue at 49H. None of the 
other proteins, including other PC binding proteins published to-date, 
which utilize the same V^ segment (99 in total), has this substitution. 
Other amino-acid substitutions which may contribute to the carrier 
specificity are: threonine-to-serine at 3OH, serine-to-proline at 40H in 
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FR2, and the presence of alanine at 96H and aspartate at 97H in 
CDR3. 
The importance of the observed amino-acid changes to the 
specificity of Mab2 may be examined by looking at the crystal 
structure of M603 (section 1.4). All the residues in M603 involved in 
directing binding to PC also present in Mab2. The carrier specificity 
in Mab2 may be due to 2 possibilities. Firstly, the amino-acid 
substitutions at 3 OH, 40H and 49H individually or collectively, can 
alter the conformation of CDRl (H) and CDR2 (H) and consequently 
interfere with the pairing of the H and L chain; the binding site thus 
becomes more restricted. Secondly, amino-acid substitution 
(Asp97H), addition (Ala96H) or deletion (SerlOObH) may affect 
proper pairing between CDR3 (H) and CDRl (L), which makes CDRl 
(L) much more exposed to the outside. 
This study concentrates on the first hypothesis, that the 3 OH, 
40H and 49H amino-acid substitutions are important. Regarding the 
proline-to-serine substitution at 40H, structural change has indeed 
been noted in the M603 Fv when proline was replaced by glycine 
since this interfered with the expression and stability of the protein 
(Knappik and Plunkthun, 1995). In the case of the alanine-to-glycine 
change at although the nature of the substitution is conservative 
(Fig. 15), in the M603 model, alanine forms a hydrogen bond with 
Trp36H to maintain the tertiary structure of the molecule. Also, since 
alanine is located at the beginning of CDR2 (Fig. 16), any change in 
this position can greatly influence the CDR2 conformation. In 
contrast, the serine-to-threonine substitution at 3OH is frequently 
found in many PC-binding antibodies (Kabat et al., 1991)and, as a 
result, may not be critical. 
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Figure 15 Amino acid properties. 
Schematic drawing of the properties of 20 common amino acid 
according to their properties of side chain component. 
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Figure 16 Intra-chain hydrogen bonds of McPC603. 
Schematic drawing of (a) VH, (b) VL domains illustrating the 
hydrogen bonds between the main chain amino acid residues.. 
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To investigate whether the particular residues at 40H and 49H in 
Mab2 contribute to the unique carrier specificity of the molecule, my 
plan is straightforward: change these residues to the "wild type" found 
in the prototypic M511 protein, and see whether this destroys the 
carrier specificity. This can be carried out by site-directed 
mutagenesis of the Mab2 genes. I decided to use the newer phage-
display system rather than mammalian cell expression because this is 
simpler. I report the difficulties encountered with using the phage-
display system, namely, that the antibody transformed in this way (as 
scFv) is not exactly the same as the hybridoma antibody. This is the 
first time a critical comparison has been made between the two forms 
of antibody: the difference is very subtle, but this matters importantly 
to the present objective of understanding the structural basis of carrier 
specificity. Previously, investigators have only compared the 
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Figure 18 Outline of Analysis for Mab2-scFv binding activities in both phage-
displayed and soluble scFv forms. 
40 
CHAPTER 2 MATERIALS AND METHODS 
2.1 ANTIBODY 
Mab2 and Ts2 antibody were prepared as described in 2.1.2. 
2.1.1 Hybridoma culture 
Mab2 and Ts2 hybridoma were cultured in RPMI 1640 
medium (GIBCO BRL, Rockville, Maryland, USA) supplemented with 
10% heat-inactivated fetal bovine serum (GIBCO BRL, Rockville, 
Maryland, USA) and penicillin (lOOjiig/ml) and streptomycin (lOOjug/ml) 
by incubating at 37°C with 5% CO�. 
2.1.2 Production of antibody by induction of ascitic fluid 
Adult female BALB/c mice of 7 weeks were primed by 
injection of 0.5ml incomplete Freund's adjuvant (Sigma, St. Louis, MO, 
USA) into the peritoneum. After 2 days, 5x10^ hybridoma cells in 1ml 
PBS was injected into the peritoneum with an 18-G needle and 5ml 
syringe. Ascitic fluid was collected after 2 weeks with 18-G needle and 
5ml syringe. Then, the ascitic fluid was incubated at 37°C for 1 hr and 
the aqueous supernatant was harvested by centrifiigation at 3,000g for 10 
min. 
2.1.3 Antibody purification 
Antibody was concentrated and partially purified by 
ammonium sulfate precipitation before subject to staphylococcal Protein 
A affinity chromatography (Lim, 1987). 
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2.1.3.1 Ammonium sulfate precipitation 
High molecular weight protein was partially removed by 
addition of half volume of saturated ammonium sulfate (Sigma, St. 
Louis, MO, USA) into the clear ascitic fluid with continuous stirring. 
The mixture was stood on ice for 2 hr before centrifuging down the 
precipitate by 3,000g, 4 � C for 30 min. Another half volume of saturated 
ammonium sulfate was added to make the final saturation to 50%. The 
mixture was stand at 4°C overnight to precipitate down the antibody. 
The antibody was collected by centrifiigation at 3,000g, 4°C for 30 min. 
The pellet was re-dissolved with PBS and dialysed with PBS for three 
overnight with daily exchange of buffer to completely remove the 
ammonium sulfate. 
2.1.3.2 Affinity purification by Protein A-Sepharose 
Protein A bind to the C^l and inter-domain of mouse Ig. 
Although Mab2 is a IgGl antibody which has a weaker affinity with 
protein A, the heavy chain variable region encoded by SI07 family gene 
can also bind to Protein A. Protein A-Sepharose (Sigma, St. Louis, MO, 
USA) was equilibrated with PBS for 1 hr at room temperature. 
Antibody partially purified by ammonium sulfate precipitation from 
ascitic fluid was mixed with Protein A-Sepharose at 4 � C overnight using 
a roller mixer. The beads were spun down at l,000g for 3 min. Then, 5 
beds volume of PBS was added to wash out the unbound protein. 
Washes were repeated 4 times until no absorbance at 280nm could be 
detected from the supernatant by spectrophotometry. Antibody captured 
by the Protein A column was eluted by O.IM glycine-NaOH pH 11.0. 
The eluted antibody was neutralized by 1/10 volume of IM Tris-Cl pH 
7.4 before dialyzed with PBS at 4°C overnight. Antibody concentration 
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was determined by measuring the absorbance at OD 280mn corrected 
with the extinction coefficient of IgG (A280=1.43 for Img/ml). 
2.1.4 Production of Fab fragment by papain digestion 
40jig of protein A affinity purified Mab2 antibody was 
digested with lOng papain (Sigma, St. Louis, MO, USA) in digestion 
buffer (lOOmM sodium acetate pH 5.5, 50mM cysteine and ImM 
EDTA). The reaction mixture was incubated at 37°C for 16 hr to reach 
the complete digestion point determined before. The reaction was 
stopped by addition of iodoacetamide (Sigma, St. Louis, MO, USA) to a 
final concentration of 75mM, followed by incubation at room 
temperature for 1 hr to inactivate the papain. The antibody fragments 
was dialyzed with PBS overnight to remove the iodoacetamide and 
standardized to 16jLig/ml before analyzed with SDS-PAGE and ELISA. 
2.2 ANTIGENS 
Three phosphorylcholine-containing antigens were used in 
this study. These included the whole worm lysate of the Trichinella 
spiralis LI muscular larvae (TsAg) in both crude and affinity purifeid 
forms, PC conjugated human serum albumin (PC-HSA), and 
Pneumococcal polyvalent vaccine -Pneumovax® 23 (PnX). TsAg and 
PC-HSA were prepared in the laboratory. PnX was purchased from 
Merck Sharp and Dohme, West point, PA. An other non-PC containing 
antigen, lipopolysaccharide (LPS) used as control antigen was purchased 
form Sigma, St. Louis, MO, USA. 
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2.2.1 Preparation of TsAg from infected ICR mouse 
ICR mice infected by Trichinella spiralis for 6 weeks were 
killed and after the skin, heart, lung, liver, kidney and intestine were 
discarded, the mice bodies were digested with pepsin in 1% (w/v) HCl at 
37°C for overnight in a shaking incubator. Larvae were passed through 
a wire gauze (400 hole per cm^), washed extensively three times by s 
normal saline at room temperature. The whole worm extracts (TsAg) of 
Trichinella spiralis muscular LI larvae were prepared by 30 cycles of 20 
sec sonication of the isolated worm (Choy et al., 1988). The sonicate 
was solublized in 0.1% Trition-XlOO by rolling at 4°C overnight. 
Remaining debris was removed by centrifugation at 13,000 rpm for 5 
min. The supernatant was standardized to 2mg/ml and stored at -20°C 
until used. 
2.2.2 Purification of Trichinella spiralis PC antigen 
Purified Trichinella spiralis antigen (pTsAg) was obtained 
from TsAg by affinity chromatography using Mab2 antibody. 
2.2.2.1 Preparation of the Mab2 affinity column 
lOOmg Sepharose 4B-CNBr beads (Sigma, St. Louis, MO, 
USA) was swelled and activated with 3ml 0.00IN HCl for 20 min at 
room temperature. The beads were washed with 10ml PBS twice and 
equilibrated with bicarbonate coupling buffer (O.IM NaHCOs + 0.5M 
NaCl pH8.3). Antibody diluted in bicarbonate coupling buffer was 
coupled to the activated beads by continuous mixing at 4°C for overnight. 
Then, the beads were washed with excess bicarbonate coupling buffer 
before saturating the active site in the beads by addition of l.OM glycine 
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pH8.0 for 30 min. The loosely bound antibody and glycine were eluted 
by 0.0IN H Q for 5 min, and the column was washed by excess PBS. 
2.2.2.2 Purification of TsAg 
The whole worm extract of Trichinella spiralis larvae LI 
from 2.2.1 was diluted in PBS and mixed with the Mab2-sepharose 
overnight by a roller at 4°C. The unbound fraction was removed by 10-
bed volume of PBS, and then Mab2 reactive TsAg was eluted by 0.05M 
glycine-NaOH pH 11.0. The purified TsAg was dialyzed with PBS in 
the dialyzing tubing (molecular cutoff at 10-12kD) at 4°C overnight. 
The purified TsAg was stored in lOOjug/ml at -20°C. 
2.2.3 Preparation of PC-HSA 
2.2.3.1 Preparation of p-diazonium phenylphosphorylcholine (DPPC) 
150mg p-aminophenylphosphorylcholine (Sigma, St. Louis, 
MO, USA) was dissolved with 7.5ml ice-cold 0.2M HCl in a 10ml 
breaker. Freshly prepared 0.2M NaN02 (Sigma, St. Louis, MO, USA) 
was added dropwise with continuous stirring on ice, until a testing 
aliquot (lOjil) of the mixture gave a dark-blue color when reacted with 
starch-iodide paper. The DPPC generated was aliquoted into 3ml per 
tube and frozen immediately at -80°C. 
2.2.3.2 Conjugation of PC to HSA 
66.6mg HSA (Sigma, St. Louis, MO, USA) was dissolved in 
8.33ml ice-cold 0.2M HCl. 2.2ml DPPC mixture was added dropwise 
with continuous stirring on ice within 15min. The reaction mixture was 
transferred to cold room and stirred overnight. Reaction mixture 
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developed a light yellowish color and was dialyzed with 2L O.IM PBS 
for 4 days with buffer change daily. The PC-HSA was collected and the 
concentration of HSA was measured by Lowry protein assay. The PC-
HSA was stocked in lOmg/ml at -20°C. 
2.2.4 Commercial available antigens 
2.2.4.1 Pneumovax® 23 
Pneumovax® 23 (PnX) is a pneumococcal polyvalent vaccine 
consists of a mixture of highly purified capsular polysaccharides in 
50|ag/ml each from the 23 most prevalent pneumococcal types. 
Pneumovax® 23 was used as a phosphorylcholine hapten carried on a 
polysaccharide carrier. 
2.2.4.2 Lipopolysaccharide 
Lipopolysaccharide was purchased from Sigma in pure form. 
2.2.5 Standardization of PC-antigens 
The PC content on TsAg, PnX and PC-HSA was 
standardized by titration with the PC specific antibody Ts2. Serial 
dilutions of PC-antigens were coated on ELISA plate in bicarbonate 
coating buffer pH9.6 at 4°C for overnight. The unoccupied coating sites 
were blocked with 2.5% BSA (Sigma, St. Louis, MO, USA) in PBS. 
Serial dilution of Ts2 antibody starting from 2j^g/ml was added and 
incubated for 2 hr. The bound Ts2 antibody was detected with goat anti-
mouse IgG peroxidase conjugates (Sigma, St. Louis, MO，USA) using 
0.01% 0-phenylenediamine (OPD) (Sigma, St. Louis, MO, USA) as 
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substrate. Results were read at 490nm. The relative PC content was 
determined by using the PC-HSA conjugate as standard. 
2.3 CLONING OF MAB2-SGFV INTO PHAGE DISPLAY 
FORM 
Cloning of phage-displayed Mab2-scFv was done by using 
the reagents and strategy of the Recombinant Phage Antibody System 
obtained from Pharmacia Biotech (Fig. 17). The primers used for 
cloning are listed in Table 3 are adopted from Hoogenboom, H.R. group 
(Clackson et al., 1991). ScFv are expressed and analysed as shown in 
Fig.18. 
• • • . - • • 
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Table 3 Primer sequence 
PCR primer for V genes 
Heavy chains: 
VHIBACK 5'AG GTS M A R C T G C A G S A G T C W G G 3， 
VHirOR-2 5' TGA GGA GAC GGT GAC CGT GGT CCC TTG GCC CC 3, 
Lighe chains: 
V K 2 B A C K 5 ’ G A C A T T G A G CTC A C C C A G TCT C C A 3， 
MJKIFONX 5, C C G TTT G A T TTC C A G CTT G G T G C C 3, 
MJK2rONX 5 ’ C C G TTT T A T TTC C A G CTT G G T C C C 3， 
MJK4FONX 5，CCG TTT T A T TTC C A A CTT T G T C C C 3， 
MJK5FONX 5 ‘ C C G TTT C A G CTC C A G CTT G G T C C C 3， 
Linker fragment PCR primers 
LINK BACK 
5，GGG A C C A C G G T C A C C G T C T C C T C A G G T G G A G G C G G T T C A 
G G C G G A G G T G G C TCT G G C G G T G G C G G A T C G G A C A T C G A G 
CTC A C T C A G T C T C C A 3’ 
LINK FOR 
5 ‘ T G G A G A C T G A G T G A G CTC G A T G T C C G A T C C G C C A C C G C C 
A G A G C C A G G T C C G C C T G A A C C G C C TCC A C C T G A G G A G A C 
G G T G A C C G T G G T C C C 3， 
Restriction sites introduction primer (restriction enzyme site are underlined) 
VHlBACKSfi 5, G T C C T C G C A A C T G C G G C C C A G C C G G C C A T G G C C 
C A G GTS M A R C T G C A G S A G T C W G G 3， 
JKINOTIO 5, G A G T C A T T C T G C G G C CGC CCG T T T G A T T T C C A G 
CTT G G T G C C 3' 
JK2NOT10 5, G A G T C A TTC T G C G G C C G C C C G TTT T A T TTC C A G 
CTT G G T C C C 3' 
JK4NOT10 5，GAG T C A TTC T G C G G C C G C C C G TTT T A T TTC C A A 
CTT T G T C C C 3' 
JK5NOT10 5, G A G T C A TTC T G C G G C C G C C C G TTT C A G CTC C A G 
CTT G G T C C C 3' 
RS primers (restriction enzyme site are underlined) 
V H I B A C K Sfil 5' G T C CTC G C A A C T G C G G C C C A G C C G G C C A T G 
G C C C A G GTS M A R C T G C A G S A G T C W G G 3 ’ 
J K Nod 5, G A G T C A TTC T G C G G C C G C C C G TTT K A T TTC 
C A R CTT K G T S C C 3’ 
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Sequencing primer 
pCANTABS-Sl 5 ‘ C A A C G T G A A A A A A T T A T T A T T C G C 3 ‘ 
pCANTAB5-S3 5，GGT T C A G G C G G A G G T G G C T C T G G 3, 
pCANTAB5-S4 5 ’ C C A G A G C C A C C T C C G C C T G A A C C 3, 
pCANTAB5-S6 5 ’ G T A A A T G A A TTT T C T G T A T G A C C 3, 
Mutagenesis oligo 
Frame2772+A 5 ‘ G A C A G G A T T T G G A G A C T 3 ’ 
Tm(50mM NaCl)=36.99 
2437L19-40H 5 ‘ T C C C T G G A G G C T G G C G G A C 3 ‘ 
Tm(50mM NaCl)=61.83 
2467L18-49H 5' T C T A C T T G C A G C A A T C C A 3, 
Tm(50mM NaCl)=44.12 
2604L19-89H 5 ‘ A C A G T A A T A A G T G G C A G T G 3， 
Tm(50mM NaCl)=39.32 
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2.3.1 Total RNA extraction 
Total RNA of Mab2 hybridoma was isolated by acid 
guanidinium thiocyanate-phenol-chloroform extraction method 
(Chomczynski and Sacchi, 1987) with all the chemical reagent 
purchased from Sigma, St. Louis, MO, USA. lO? Mab2 hybridoma cells 
were harvested from 6-well tissue culture plates and washed with ice-
cold PBS. After spinning down the cell by centrifugation, 250|il of 
denaturing solution (4M guanidinium thiocyanate, 25mM sodium citrate, 
0.5% sarcosyl, O.IM 2-mercaptoethanol) was added, followed by 50|il 
2M sodium acetate (pH 4.0), 500|il phenol-water saturated and lOOjil 
chloroform-isoamylalcohol mixture (49:1). The mixture was mixed 
thoroughly by inversion after the addition of each reagent. The final 
suspension was shaken vigorously for 10 sec and chilled on ice for 15 
min. The RNA present in aqueous phase was obtained by centrifuging 
the mixture at 13,000 rpm on bench top centrifuge for 20min at 4°C. 
The total RNA was precipitated by addition of 1ml isopropanol and 
store at -20�C for 1 hr. The precipitated RNA was harvested by spinning 
at 13,000 rpm for 20 min at 4°C. The RNA was re-dissolved in SOOjiil 
Denaturing solution and re-precipitated with addition SOOjul of 
isopropanol. The RNA was pelleted by centrifugation at 13,000 rpm for 
45 min at 4�C, and washed by 70% ice-cold ethanol before dissolving it 
• • . -
in 30|LI1 DEPC-water at 65�C for 10 min. 
2.3.2 cDNA synthesis 
cDNA was synthesized by reverse transcriptase (GIBCO 
BRL, Rockville, Maryland, USA) with 2|al of 50ng/|Lil extracted RNA in 
Ix PGR buffer (GIBCO BRL), 5mM MgCl^ (GIBCO BRL), 4mM 
dNTPs (Pharmacia), O.S i^g Oligo dT12-18 (GIBCO BRL), 200U RT 
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(GIBCO BRL, Maryland). The reaction was incubated at 42^C for 45 
min, followed by 99^0 for 5 min to inactivate the enzyme. 
2.3.3 Heavy chain variable region gene amplification 
The heavy chain variable region gene (Vn-gene) was 
amplified by PCR reaction with 5\il of 4 ng/|Lil cDNA as template in Ix 
PCR buffer (GIBCO BRL, Rockville, Maryland, USA), 2mM MgCl: 
(GIBCO BRL), 200jLiM dNTPs (Pharmacia), Ijul heavy chain primer 1 
(VHl BACK) of 5 pmol/jLil, Ijul Heavy chain primer 2 (VHl FOR-2) of 
5 pmol/jil, 5U Taq DNA polymerase-native (GIBCO BRL). The PCR 
reaction was carried out with hot start by incubating the reaction at 9 5 � C 
for 5 min before addition of Taq DNA polymerase (GIBCO BRL). The 
reaction was run for 30 cycles for 9 5 � C 1 min, 5 5 � C 2 min, and 7 2 � C 2 
min. An extension of 7 2 � C 10 min was followed to ensure the 
completeness of the PCR reaction. PCR product was analyzed by 
running on 1.6% agarose gel in IxTBE buffer. The Vn-gene DNA was 
purified from agarose gel by QIAEX gel purification kit (QIAGEN). 
2.3.4 Light chain variable region gene amplification 
The light chain variable region gene (VL-gene) was amplified 
by PCR reaction with 5|LI1 of 4 ng/|Lil cDNA as template in Ix PCR buffer 
(GIBCO BRL, Rockville, Maryland, USA), 2mM MgCh (GIBCO BRL), 
2OO1L1M dNTPs (Pharmacia), 20pmol light chain primer mix (VK2 
BACK, MJKIFONX, MJK2F0NX, MJK4F0NX, MJK5FONX) and 5U 
Taq DNA polymerase-native (GIBCO BRL). The PCR reaction was 
carried out with hot start by incubating the reaction at 9 5 � C for 5 min 
before addition of Taq DNA polymerase. The reaction was run for 30 
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cycles for 95°C 1 min, 55°C 2 min, and 72°C 2 min. An extension of 
72�C 10 min was followed to ensure the completeness of the PCR 
reaction. The PCR product was analyzed by running on 1.6% agarose 
gel in IxTBE buffer. The VL-gene DNA was purified from agarose gel 
by QIAEX gel purification kit (QIAGEN). 
2.3.5 Joining of heavy and light chain gene with linker 
The heavy chain gene (VH-gene) and light chain gene (VL-
gene) was linked by splice overlap extension reaction. 20ng Vn-gene 
and 20ng VL-gene were mixed with Ix PCR buffer, 200|iM dNTPs, 
2.5inM MgCl2, 50pmol linker-primer mix (Linker-BACK, Linker-FOR) 
and lU Taq DNA polymerase (GIBCO BRL, Rockville, Maryland, USA) 
to link the VH and VL genes in 25^1 reaction. The reaction was 
preformed with hot start followed by incubation at 94�C 1 min and 63°C 
4 min for 7 cycles. 
50 pmol RS primer mix (VHlBACKaSy//, JKINOTIO, 
JK2NOT10, JK4NOT10, JK5NOT10) and 5U Taq DNA polymerase 
were added to the above reaction for the generation of the VH-linker-VL 
gene by 94�C 1 min, 55�C 2 min, 72�C 2 min for further 30 cycles. The 
Vn-linker-VL fragment was analyzed by 1% agarose gel and purified by 
QIAEX gel purification kit (QIAGEN). 
2.3.6 Ligation of scFv gene with pCANTAB-5E vector 
The purified Vn-linker-VL fragment was digested by lOU Sfil 
(NEB) in Ix One-Phor-All buffer (Pharmacia) at 50�C for 3 hr with 
mineral oil overlay to prevent evaporation. The Sfil enzyme was heat 
denatured by incubation at 85°C for 30 min. The Sfil digested VH-
linker-VL fragment was then digested with 5U NotI (NEB) in Ix One-
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Phor-All buffer supplement with 50mM NaCl and 0.05% Triton-XlOO at 
37°C for 3 hr. The NotI enzyme was heat denatured by incubation at 
65°C for 10 min. The Sfil and NotI digested Vn-linker-VL fragment was 
analyzed in 1% agarose gel and purified by QIAEX gel extraction kit 
(QIAGEN). 
20 pmol Sfil, NotI digested pCANTAB-5E vector 
(Pharmacia) was ligated with the Sfil, NotI digested Vn-linker-VL 
fragment in the ratio of 1:0; 1:1; 1:3 and 1:5 by 5U of T4 DNA ligase 
(GIBCO BRL, Rockville, Maryland, USA) in Ix T4 ligase buffer 
[50mM Tris-HCl(pH7.6), 10mMMgC12, ImMATP, ImMDTT, 5%w/v 
polyethylene glycol-8000]. The ligation reactions were incubated at 
14�Cfor l6hr . 
2.3.7 Transformation 
Two methods were employed to transfer plasmid DNA into 
E.coli host. High-voltage electroporation was used to yield the 
maximum transformation efficiency. Calcium chloride method was used 
for sub-cloning the construct into different E.coli host for manipulation 
and analysis. 
2.3.7.1 E.coli strains 
TGI (supE hsdD5 thi D(lac-proAB) F丨[traD36 proAB+ laclq 
lacZDM15]) and the amber non-supressing strain HB2151 were used to 
express the scFv in phage and soluble form. CJ236 (dut-1, ung-1, thi-1, 
rel A-1; pCJ105 (Cmr)) was used in mutagenesis. The F positive 
colonies of E.coli were selected by growing on M9 (6 g Na2HP04, 3 g 
KH2PO4, 1 g NH4CI, 0.5 g NaCl, 3 mg CaCy minimal medium agar. 
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2.3.7.2 E.coli cell preparation for electroporation 
2.5ml overnight bacterial culture was transferred to 500ml 
2xYT (16 g tryptone, 10 g yeast extract, 5 g NaCl per liter) in IL conical 
flask. The culture was incubated at 3TC for 2-3 hr with mild shaking 
until ODgoo reach 0.9. The bacteria pellet was collected by 
centrifugation at 2，000g for 10 min at 4°C in Beckman GPR centrifuge. 
Bacteria were washed twice with ice-cold water. The cells were washed 
once with ice-cold 10% glycerol and re-suspended in 10% glycerol at a 
concentration of 3x10^^ cells/ml. The cells were then allocated into 
50|Lil/vial, frozen in dry ice, and stored at -70�C. 
2.3.7.3 Electroporation 
Ligation product was desalted by addition of 2|il 2% 
glycogen as the co-precipitator, 1/10 volume of 3M sodium acetate pH 
5.2 and 2 volume of ethanol at -20°C. The DNA pellet was re-dissolved 
in l O j L i l DDHSO. 5jil of ligated DNA was mixed with 50|al 
electroporation cell and then transferred to pre-chilled cuvette. The 
electroporation was performed by Gene-pulser (Bio-Rad) at 2.0KW, 
25uF，200Q with the time constant (T) about 3.8 to 4.1 msec. The 
mixture was immediately transferred to 1ml SOC (0.5% yeast extract, 
2% tryptone, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM 
MgS04, 20 mM glucose) and incubated at 37°C for 1 hr before 
spreading the cells on 2xYT agar plate with lOOjug/ml ampicillin and 2% 
glucose. 
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2.3.7.4 Competent E.coli preparation by CaCl� 
250|il overnight bacterial culture was transferred to 50ml 
2xYT in 250ml conical flask. The culture was incubated at 37°C for 90-
120 min with mild shaking until ODgoo reach 0.3. The bacteria pellet 
was collected by centrifuge at 2,000g for 10 min at 4 � C in Beckman 
GPR centriftige. Bacteria were re-suspended in 20ml ice-cold lOOmM 
CaCl2 and incubated on ice for Ihr. After centrifugation, the bacteria 
pellet was re-suspended with 2ml lOOmM CaCl�. The competent cell 
was aliquot into 200)al/tube and stand on ice until use. 
2.3.7.5 Heat shock 
Ligation product was mixed with 2 0 0 j L i l competent cell on ice 
for 1 hr. The mixture was subjected to heat shock by immersing the tube 
to a water-bath at 42°C for 90 sec, followed by chilling the tube on ice 
for 15 min. 0.8ml 2xYT was added and the tube was incubated at 37�C 
for 1 hr before spreading the cells on 2xYT agar plate with lOOjug/ml 
ampicillin and 2% glucose. 
2.4 EXPRESSION OF PHAGE DISPLAYED ScFv 
1ml bacterial culture in 2xYT supplement with lOOjag/ml 
ampicillin and 2% glucose (2xYTAG) was expended from overnight 
culture of a single colony at 37°C with 225 rpm shaking until OD^ oo 
reached 0.3 (3X10^ cell/ml). 150|il of M13K07 helper phage (Vieira 
and Messing, ) (titer >1x10" particles per ml) was added to make the 
super-infection efficiency at 1:50. The culture mixture was stood at 
370c for 1 hr for super-infection. Then, the bacteria cells were pelleted 
down and re-suspended in 2ml of 2xYT supplement with 100|ag/ml 
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ampicillin and 50|ig/ml kanamycin (2xYTAK) to select the helper phage 
infected bacteria to express the recombinant scFv bearing phage particle. 
The final bacterial culture was grown at 37�C with 225 rpm shaking for 
16 hr. The phage particles were harvested by separating the bacterial 
cells and debris by centrifugation at 8000g for 20 min. 
The phage particles were precipitated by addition of 1/5 
volume 20% PEG6000 (Merck, Darmstadt, FRG), 2.5M NaCl. The 
mixture was stood on ice for 1 hr before the precipitated phage particles 
were centriftiged down at l，2000g for 30 min. The phage pellet was re-
dissolved in PBS and dialyzed overnight with PBS to remove remaining 
PEG contamination. 
Phage harvested in different dilution factor form lO? to lO!� 
were added to 1ml of TGI cells at 37°C for 45 min and the infected cells 
were plated on 2xYTAG plates, and the colony forming unit (c&) were 
then determined. 
2.5 ENRICHMENT AND SCREENING OF Mab2-scFv 
PHAGE 
The scFv bearing phages were selected by their specific 
binding affinity to the target antigen (TsAg) on microtiter well format. 
2.5.1 Biopanning 
The phages expressed from a pool of transformants of the 
pCANTAB-5E-VH-linkerVL ligation were concentrated 50x by PEG 
precipitation method. lOOjal of the concentrated phage was mixed with 
10|il 25%BSA/PBS to make the final BSA concentration to 2.5% as a 
blocking protein for biopanning. The llOjul phage in 2.5%BSA/PBS 
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was added to 2.5%BSA pre-blocked Immuno 2® microliter stripe 
(Dynatech, Alexandria, VA) coated with lOOjul of l^g/ml Mab2 affinity 
purified TsAg (pTsAg). The phage was incubated with the pTsAg at 
37°C for 30 min without shaking and 60 min at room temperature with 
shaking (300 rpm) by microliter plate shaker. The microtiter well was 
washed three times with 200|il/well 2.5%BSA/PBS at 900 rpm shaking 
for 2 min each. Then, the well was subjected to a more stringent 
washing for three times by 0.05% Tween 20/PBS at 900rpm shaking for 
2 min. 
The phage bound to the pTsAg was eluted with 100 jul 0.05M 
glycine-NaOH, pH 11.0 with shaking (900 rpm) for 10 min. The eluted 
phage was immediately neutralized by addition of lOjil of 1 Ox PBS pH 
7.4 and 10|LI1 of IM Tris-HCl pH 7.4. 
All unbound phage supematants, wash buffers and elutes 
were saved for phage titer assay, ELISA assay and PCR screening. The 
eluted phage was used to infect TGI (OD600=0.3) by incubating at 37�C 
for 1 hr. M13K07 helper phage was subsequently added to superinfect 
the TGI for the expression of the enriched phage population. 
The biopanning was repeated twice. The eluted phage from 
the third round of biopanning was used to infect TGI and the cell 
mixture was spread out on 2xYTAG plates. Single colony isolated was 
tested for the presence of insert by PCR, restriction fragment analysis, 
DNA sequencing. The binding activity of the phage was tested by direct 
ELISA with TsAg. 
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2.5.2 Restriction fragment analysis 
The DNA prepared by alkali lysis method was used for 
restriction fragment analysis. Restriction endonuclease Hind III, Ava II, 
Sac I, Mine II enzymes (NEB) (predicted from the DNA sequence of the 
construct) were used to map the plasmid DNA of the isolated clones. 
10|ig plasmid DNA was digested by 5U enzyme in combination of 
Hindlll/HincII, Hindlll/SacI, HincII/Avall and Avail alone at 37�C for 4 
hr. The size of digested DNA for each combination were analyzed by 
1 % agarose gel in Ix TBE buffer. 
2.5.3 PCR screening 
5pmol RS primer in Ix PCR buffer (GIBCO BRL), 2mM 
MgCl2 (GIBCO BRL), 200|iM dNTPs (Pharamcia) and lU Tag DNA 
polymerase (GIBCO BRL) were mixed. The reaction was carried out at 
95°C for 1 min, 55�C for 1 min, TTC for 2 min for 25 cycle. An 
extension period of 10 min at 72°C was followed before the reaction was 
terminated by chilling at 4°C. The PCR product was analyzed by 
running on 1% TBE agarose gel. 
2.5.4 DNA sequencing 
2.5.4.1 Manual sequencing 
DNA sequencing was done by a I hcnno Sccjiicnasc Cyclc 
Sequencing Kit (Aniersham), and a dsDNA Cyclc Sequencing System 
(GIBCO BRL). The templates for sequencing arc ihc plasmid DNA 
prepared by alkali lysis method. The DNA sequences were analyzed by 
running on 6% acrylamide gel containing 7M urea, under constant power 
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supply of 60W and maximal gel temperature at 55�C. The radiolabeled 
DNA fractionated on the gel was detected by autoradiography. 
2.5.4.2 Auto-sequencing 
The dRhodamine Terminator Cycle Sequencing Ready 
Reaction Kit was used and the labeled ssDNAs were analysed by an 
autosequencing machine ABI PRISIVTM 310 (Perkin-Elmer). 5jug of 
plasmid DNA and 3.2pmol sequencing primer were added to the 4JLI1 of 
reaction mix and the final volume was adjusted to lOjiil by water. The 
reaction was carried out in a thermalcycler using a program of 96°C for 
10 sec, 50�C for 5 sec, 60°C for 4 min for 35 cycles. The reaction was 
terminated by chilling at 4°C. The unincorporated dye terminators were 
removed by passing through Spin G-50 column (Pharmacia) at 3000 rpm 
for 1 min. Template suppression reagent of half of the reaction volume 
was added to maintain the DNA in denature form after heat denaturation 
at 95�C for 2 min. 
2.6 MUTAGENESIS 
The single base mutations were performed as previously 
described by Kunkel method. Single-stranded DNA containing a small 
number of uracil (U) residues for replacement of thymine was prepared 
from a dur ung- strain (CJ236). A synthetic oligonucleotide (IDT, 
Table 3) containing the mutation of interest is phosphorylated, annealed 
to the template and extended with T4 DNA polymerase. The nick 
generated was ligated with T4 DNA ligase to produce a heteroduplex 
double-stranded circular molecule. Introduction of this heteroduplex 
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molecule into a dut+ ung~^ strain (TGI-wild-type) allows efficient 
recovery of mutant DNA. 
2.6.1 Preparation of uracil containing ssDNA 
Phage was similarly expressed as described in 2.4, except that 
the insert containing plasmid was subcloned into E.coli strain CJ236. In 
addition, 2xYTAK medium supplemented with uridine (0.25jig/ml) was 
used for replacement of some thymine residue with uracil in the phage 
ssDNA. The phage particles purified with PEG precipitation were re-
suspended in TE buffer. The single-stranded phage DNA were extracted 
twice with equal volume of phenol and subsequently precipitated with 
two volume of 100% ethanol at -20°C in the present of 0.3M sodium 
acetate pH 5.2. The DNA concentration of was determined by 
spectrophotometrically at 260nm. 
. . • • • • , . ‘ 
2.6.2 Phosphorylation of mutagenic oligonucleotide 
SOOpmol oligonucleotide was mixed with the 
phosphorylation cocktail [5mM ATP, Ix kinase buffer (GIBCO BRL)], 
lOU polynucleotide kinase and the final volume was adjusted to 20]LI1 by 
water. The oligonucleotide was incubated at 37�C for an hour and the 
kinase was heat inactivated at 68�C for 10 min. The final 
oligonucleotide concentration is 15pmol/|il. 
2.6.3 Hybridization and secondary strand synthesis 
Phosphorylated oligo was hybridized with the single-stranded 
circular DNA (uracil-containing). After heating the mixture (lOjil) [15 
pmol oligo and 1.5 jiig ssDNA in PEl (20mM Tris.Cl pH7.5, lOmM 
MgCl2, 50mM NaCl, ImM DTT)] to 85�C in 50ml water bath, the oligo 
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was hybridized to DNA template as the water bath cool to room 
temperature. The hybrid was stabilized by transferring the cocktail to 
ice bath. 
PES (lOjLil) containing PE2 (20mm Tris.Cl pH7.5, lOmM 
MgCl2, 1mm DTT), ImM dNTPs，ImM ATP, 6 Weiss units T4 ligase, 
T4 DNA polymerase (3U) were added to the annealed oligo-template 
hybrid. The secondary strand was synthesized by T4 DNA polymerase 
by incubating the reaction mix at 0°C for 5 min, room temperature for 5 
min and 37°C for 2 hr. The nick of the secondary strand was filled up by 
T4 ligase by incubating at 16°C overnight. 
2.6.4 Transfection and screening of mutants 
The double-stranded DNA product containing the mutant 
heteroduplex was transfected into TGI (img+ strain of E.coli) by 
electroporation. The untreated uracil containing ssDNA template was 
used as the control for the non-uracil selection by TGI host. Colonies 
was randomly chosen for mutant analysis by DNA sequencing. 
2.7 EXPRESSION OF SOLUBLE scFv-E-TAG 
Plasmid DNA prepared by max-prep column (QIAGEN) was 
subcloned into E.coli strain HB2151 by calcium chloride method. 
Clones selected by ampicillin resistance were confirmed by PGR and 
restriction enzyme mapping. 
Bacteria culture in SB medium containing lOOjig/ml 
ampicillin was expanded from overnight culture of a confirmed clone 
grown in SB supplemented with 2% glucose and lOOjig/ml ampicillin. 
When 0 D _ of the culture reach 0.3, IPTG was added to final 
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concentration of ImM for the induction of scFv expression. After 16 hr 
incubation at 37°C, with shaking at 250 rpm, the bacteria cells were 
harvested by centrifuging at 8,000g for 30 min at 4�C. The periplasmic 
fraction containing the soluble scFv was extracted by incubating the 
bacteria in TE pH 8.0 for 1 hr on ice. Bacterial cell were centrifuged 
down at 8,000g for 20 min at 4°C. The supernatant containing soluble 
scFv was taken and dialyzed overnight with 3 exchange of PBS. 
2.7.1 SDS-PAGE analysis 
The periplasmic extract of the soluble scFv was analyzed on 
12% SDS-PAGE using the periplasmic extract of the HB2151 E.coli 
host as control. The SDS-PAGE was performed as prevously described. 
2.7.2 Anti-E-tag ELISA 
The presence of soluble scFv-E-Tag recombinant was tested 
by direct binding ELISA. The periplasmic extract from both the plasmid 
containing HB2151 and the blank HB2151 were dissolved in bicarbonate 
coating buffer (pH9.6) and used to coat the ELISA plates. After 
overnight incubation at 4°C, the plate was pre-blocked by 2.5% 
BSA/PBS for 1 hr before the addition of anti-E-tag antibody peroxidase 
conjugate at 1:4000 dilution. The signal was then developed by OPD 
substrate. 
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2.8 ELISA BINDING ASSAY 
All binding assays were performed by Enzyme Linked 
Immunosorbent Assay (ELISA). Antigens were coated onto Immimo2® 
microliter plate (Dynatech) by overnight incubation at 4°C in 
bicarbonate coating buffer pH 9.6. The unoccupied site and the non-
specific binding were blocked by 2.5 % BSA in PBS. In between each 
addition of reagent, unless specifically indicated, the plates were washed 
twice with 0.05% Tween 20 in PBS. Followed by incubation with 
peroxidase conjugated antibody, the signal of binding derived from OPD 
substrate was measured by absorbance development at 490mn. 
2.8.1 Specificity of Mab2 antibody Fab 
The protein region on Mab2 antibody responsible for the 
carrier specific anti-phosphorylcholine binding on TsAg was tested by 
releasing the Fab region and Fc part by papain digestion on the antibody 
hinge region. The reactivity of Fab, Fc, and antibody on different PC-
antigens were detected by biotinylated anti-Fab antibody, biotinylated 
anti-Fc antibody and peroxidase conjugated goat anti-mouse Ig whole 
molecule antibody, respectively. 
2.8.1.1 Carrier specificity assay 
Immuon-2 microplates (Dynatech, Alexandria, VA) were 
first coated with PC-antigen, pTsAg, PC-HSA and PnX, standardized by 
Ts2 antibody titration (section 2.25) in bicarbonate buffer (pH 9.6) 
overnight at 4°C. Folowing coating, and between all subsequent steps, 
wells were washed three times with 0.05% Tween-20 in PBS. The 
plates were then blocked with 2.5% BSA in PBS for 1 hr at 37°C, 100 |il 
of serial diluted papain-digested Mab2 antibody (starting with 10|ig/ml) 
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were then added and incubated for 2 hr at 37°C. After washing, the 
wells were incubated with biotinylated anti-Fab antibody (Sigma) 
(1:4000), biotinylated anti-Fc antibody (Sigma) (1:4000) or peroxidase 
conjugated goat anti-mouse Ig whole molecule antibody (Sigma) 
(1:1000) for 1 hr at 37°C. Following subsequent washing, avidin 
peroxidase (1:2500) were added to biotinylated antibodies system and 
incubated for another hour. The reaction was developed with 0.01% O-
phenylenediamine (OPD) for 30 min and stopped by 25|il 2M H2SO4 to 
each well. Results were read at 490nm. Intact Mab2 antibody (starting 
with l)ig/ml) and intact Ts2 antibody (starting with 2|ig/ml) were used 
in parallel as controls. 
2.8.1.2 Free hapten inhibition assay 
The procedure was similar to the standard ELISA method 
described above. TsAg was coated on ELISA plate and non-specific 
binding sites was pre-blocked with 2.5% BSA/PBS, but serially diluted 
(1:5) phosphorylcholine chloride and p-nitrophenylphosphorylcholine 
starting from lO'^ M were pre-mixed with constant amount of Mab2 Fab, 
Mab2 antibody and Ts2 antibody before adding to the ELISA plate 
(lOOjil/well). Mab2 Fab were detected with biotinylated anti-Fab 
antibody and Mab2 and Ts2 antibodies with peroxidase conjugated goat 
anti-mouse Ig antibody. 
2.8.2 Specificity of the scFv 
The anti-phosphorylcholine binding specificity of the 
transformed scFv were tested by several methods which included (1) 
direct binding to PC antigen (TsAg, pTsAg, PnX, PC-HSA) and non-PC 
antigens (lipopolysaccharide — LPS), (2) free haptens inhibition and 
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PC-antigens inhibition, and (3) inhibition on the binding of Ts2 and 
Mab2 antibody to PC-antigens. In these assays, purified scFv in both 
phage-displayed and soluble forms were used to eliminate the 
interference of the impurity in the culture supernatant and bacteria lysate. 
2.8.2.1 Antigen binding assay 
The procedure was similar to the standard ELISA method 
described in section 2.8.1.1. PC-antigens, TsAg, pTsAg, PC-HSA and 
PnX, were coated on ELISA plate. The non-PC antigen, LPS, was as 
coated as a negative control antigen. After blocking with 2.5% BSA in 
PBS. Phage displayed scFv and M13K07 helper phage (GIBCO BRL) 
of the same order of phage titer (lO”）in serial diluted (1:2) were added 
and incubated for 2 hr at 37°C. The bound phages were detected by 
peroxidase conjugated rabbit anti-M13 antibody (Pharmacia) (1:5000). 
2.8.2.2 Free haptens inhibition assay 
Phosphorylcholine chloride, p-nitrophenylphosphoryl-choline 
and TsAg were used as inhibitors. The procedure was similar to the free 
hapten inhibition assay in section 2.8,1.2, but phage-displayed scFv in 
the same order of phage titers as in antigen binding assay were used. 
The bound phages were detected by peroxidase conjugated rabbit anti-
M13 antibody (Pharmacia) (1:5000). 
2.8.2.3 Inhibition on Ts2 and Mab2 antibody assay 
The procedure was similar to the standard ELISA method 
described in section 2.8.1.1. Serial dilution of scFv was added to TsAg 
coated plate and incubated for 2 hr at 37°C. After the removal of the 
scFv, Ts2 or Mab2 antibody at 0.6mg/ml was added and incubated for 
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another 2 hr at 37�C . Peroxidase conjugated goat anti-mouse IgG whole 
molecule (1:1000) was used as conjugate. 
2.9 AFFINITY ASSAY 
The intrinsic affinity of the soluble scFv with the valency of 1 
was measured based on fluorescence quenching of reflecting interaction 
when tyrosine and tryptophan in the antigen binding pocket bind to 
phosphorylcholine. The fluorescence quenching experiment was 
performed at 22°C using the Luminescence spectrometer LS-50B 
(Perkin Elmer) with excitation and emmission wavelength set at 280 rnn 
and 328 nm, respectively (Pluckthun and Pfitzinger, 1991). Stepwise 
addition of NPPC in PBS was performed so as to increase the final 
hapten concentration gradually. The fluorescence intensity was 
measured 10 min after each addition of hapten so as to reach the binding 
equilibrium. Maximum quenching (QmaJ is determined by subtracting 
the intensity quenching contributed by addition of excess NPPC (lOOjiiM) 
in the presence ofBSA control protein. The affinity for the native Mab2 
antibody was also determined in parallel for comparison. 
2.10 MUTANTS ANALYSIS 
The effect of amino acid substitution was studied by 
comparing the binding activity of mutants. The analysis of the mutants 
of S(40H)P, G(49H)A were performed similar to that of the wild-type 
scFv for testing PC specificity and the carrier specificity described above. 
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CHAPTER 3 RESULTS 
3.1 CLONING VH AND VL GENE OF MAB2 INTO scFv 
3.1.1 Amplification of variable region of H and L chain genes 
Variable genes were amplified using cDNA synthesized from 
the total RNA of the Mab2 hybridoma by PCR using the same specific 
primer sets for both H chain and L chain (Table 3) as those published by 
the phage-display pioneering group headed by G.Winter (Clackson et al” 
1991). As shown in Fig. 19, PCR of the variable genes of the H chain 
and L chain yielded a dominant product with size consistent with the 
predicted 366-bp for VH and 384-bp for VL. After gel purification of the 
VH and VL gene fragments, the 2 fragments, lOjug of each were linked 
together by a linker DNA containing the complementary sequence for 
the VH and VK primers, using 7 cycles of splice overlap extension PCR. 
The linked DNA fragment was further amplified by restriction sites-
bearing primers set (RS primers) in 30 PCR cycles to give an 
approximately 750-bp scFv gene product containing a Sfil at one end and 
NotI at the other (Fig. 20). After extensive digestion with Sfil and NotI 
enzymes, the scFv gene was directionally ligated to the complementary 
sticky ends on the pre-digested pCANTAB-5E vector and transformed to 
E.coli TGI host by electroporation. The bacteria were allowed to 
recover for 1 hour at 37�C. Super-infection of the M13K07 helper 
phage was then used to induce expression of the phage-displayed scFv 
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Figure 19 Variable gene fragment of heavy chain (VH) and light chain (VL) 
amplified by P G R (indicated by arrows), run on 1.5% agarose gel in 
T B E buffer by electrophoresis. 
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Figure 20 ScV\ gene Iragnicnt 
Joining ol the VH and VI. IH'R fragments v«.lib .i linker h) splice 
o\cfUp cxlciuion and amplified hy PCK、”ih SfU .irul St/il rcstriciion 
sWc bearing primer pairs 
3.1.2 Biopanning 
The scFv bearing phage was affinity-selected by the purified 
TsAg for three rounds with expansion after each round. As shown in Fig. 
21 and 22，although the eluate contained one of the lowest titers of 
phage among all the fractions in the first round of affinity selection, the 
presence of scFv insert was clearly detectable by PCR. In contrast, with 
the exception of wash fraction 1 and 3, scFv was undetectable. Thus, 
this result shows that the affinity-selection approach could enrich the 
phage population bearing the Mab2-scFv. Enhancement on binding 
activity of the phage towards TsAg became most obvious after the third 
round of selection. The phage eluted from this last round was used to 
infect TGI cells which was then spread out on 2xYT plate supplemented 
with ampicillin and glucose. A total of 7 clones were obtained for 
analysis. 
3.1.3 Genetic composition of isolated clones 
Six out of the 7 clones were found to contain the scFv by the 
PCR (Fig. 23). Plasmid DNA of these 6 clones was prepared by alkaline 
lysis and mapped by a combination of restriction enzymes, Hindlll, 
Hindi, Avail and Sad (Fig. 24). All the 6 clones showed the correct 
pattern on restriction mapping. The and VL DNA sequences of the 
clones were then analyzed by manual sequencing method, and were 
found identical to one another. The entire DNA sequence of 
pCANTAB-5E containing the Mab2-scFv is shown in Table 4. Vh 
sequence in the pCANTAB-5E was identical to that of Mab2 antibody 
from the 6th codon of FRl to the penultimate codon of FR4. The first 5 
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amino acids EVKLV were substituted by QLQLQ. This was caused by 
the backward degeneracy of the VH primer, VHIBACK (see Table 3). 
VL sequence in the plasmid was also identical to that of Mab2 with the 
exception of the region encoding the first 8 amino acids. This 
discrepancy with the Mab2 VL sequence was generated by the VL 
backward primer, VK2BACK (see Fig.25), containing mismatches with 
the VL sequence. Beginning from the codon of frame shift to the 
ensuring VL sequence could be observed. As shown in Fig. 25, this was 
likely resulted from the priming of VK2BACK to VK24 of the Mab2 
antibody in such a w a y that 7 nucleotides of the V ^ were looped out. 
This primer has been used in cloning of M603 scFv (Clackson et al., 
1991) and is supplied in the phage-display antibody system (Pharmaica). 
As seen in the sequence alignment shown in Fig. 25 between VK2BACK 
and 2 other V^ sequences, M603 and T15，the backward primer is indeed 
suitable in amplifying the sequence, in contraiy with VK24 of Mab2. To 
correct the reading frame, a nucleotide A , was inserted just next to the 
3，end of the codon by oligo-mediated mutagenesis (Fig.26). 
Mutagenesis for generating mutants to study structure-binding 
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Figure 22 Analysis of the affinity selection processes 
Upper panel: Phage titration of the wash fractions and the eluate by colony counting. 
Lower panel: Phage binding activity on TsAg of the wash fractions and the eluate 
by ELISA using the peroxidase conjugated anti-M13 antibody as the 
detecting agent. 
unconc 1。，unconcentrated culture supernatant containing 5 Ox lower phage 
concentration than the fraction for antigen selection; N D , not determined for sample 
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Figure 24 Restriction enzyme mapping 
A ) The plasmid D N A digested by a combination of enzymes, Hind 
III/Hinc II, Hind II/Ava II, Ava II alone and Hind III/ Sac I . The 
other 5 showed the same result. 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































D I E L T Q S P 
Primer VK2BACK GAC ATT GAG CTC ACC GAG TCT CCA 
V M 
VK22 (T15) ————-T- A-G - - T —— ———— 
V M 
VK8 (M603) ————-T- A-G - - A —— ———— 
V I D E L S 
VK24 (Mab2) ~ T ——-T- A-A ————GAT GAA C — — - -
Figure 25 Comparison of D N A sequences and predicted amino acids of M603 
( V K 8 ) , T 1 5 (VK22), Mab2 (VK24) with the universal primer 
V K 2 B A C K (in bold). 
Identity with the primer sequence in the top are indicated by dash. 




A T G A C C A T G A T T A C G C C A AGC T T T GGA G C C T T T T T T T T G GAG A T T T T C AAC G T G AAA AAA 
N R N I T P S F G A F F L E I F N V K K bl/51 =11/31. 
T T A T T A T T C GCA A T T C C T T T A G T T G T T C C T T T C T A T G C C G C C C A G CCG GCC A T G G C C CAG 
L L F A I P L V V P F Y A A F L P A N A F L 121/m ISl/Sl 
GTG AAA C T G G T G GAA T C T GGA GGA GGC T T G GTA CAG C C T GGG GGT T C T C T G CGA C T C T C C 
V K L V E S G G G L V F L P G G S L R L S Ifll/bl Ell/71 
T G T GCA A C T T C T GGT T T C A C C T T C A C T GAT T T C T A C A T G GAG TGG GTC CGC CAG T C T CCA 
C A T S G F T F T D F Y N E U V R F L S P 241/ai 
GGG AAG AGA CTG GAG TGG A T T GGT GCA AGT AGA AAC AAA G C T A A T GAT T A T ACA ACA GAA 
G K R L E U I G A S R N K A N D Y T T E 3D1/1D1 331/111 
T A C AGT GCA T C T G T G AAG GGT CGG T T C A T C G T C T C C AGA C A C A C T T C C CAA AGC A T C C T C 
Y S A S V K G R F I V S R D T S F L S I L 3bl/lEl 311/131 
T A C C T T C A G A T G A A T G C C C T G AGA G C T GAA 6 A C A C T G C C A T T T A T T A C T G T GCA AGA GAT 
Y L O N N A L R A E D T A I Y Y C A R D M21/im 1451/151 
GCG G A C T A C GGT AGT T A C TGG T A C T T C GAT G T C TGG GGC CAA GGG A C C ACG G T C A C C G T C 
A D Y G S Y U Y F D V I I J G ( 2 G T T V T V Mfll/lbl 511/171 
T C C T C A G G T G G A G G C G G T T C A G G C G G A G G T G G C T C T G G C G G T G G C G G A T C G GAC A T C GAG 
S S G G G i G S G G G G S G G G G S D I E 
sm/lfll • 571/131 
C T C A C T C A G T C T C C A A T C C T G T C A C T T C T G GAG A A T C A G T T T C C A T C T C C T GCA GGT CTA 
L T ( 3 S P I L S L L E N ( J F P S P A G L bDl/5Dl b31/Ell 
GTA AGA G T C T C C T A T ATA AGG ATG GGA AGA C A T A C T TGA A T T GGT T T C T G C AGA GAC CAG 
V R V S Y I R M G R H T 本 bbl/251 t11/B31 
GAC AAT C T C C T C AGC T C C TGA T C T A T T T C A T G T C C A C C C GIG C A T CAG GAG T C T C A G A C C 
721/241 ？Sl/SSl 
GGT T T A GTG GCA G T G G C T CAG GAA CAG A T T T C A C C C TGG AAA T C A GTA GAG TGA AGG C T G 
？ai/5bl flll/271 
AGG A T G T G G G T G T G T A T T A C T G T C AAC AAC T T G T A G AGT A T C C G C T C A C G T T C G GTG C T C 
fl4i/5ai a7i/aii 
GGA C C A AGC TGG AAA T C A AAC GGG CGG C C G CAG G T G C C C CGG T G C C G T A T C QGG A T C C G C 
TGG AAC C G C GT 
Figure 26 D N A sequence and translation of the defective scFv clone. 
The scFv was constructed in such a way that V ^ proceeded the linker 
(in bold), which in turn was followed by the VL. Missing of A in the 
position indicated by an arrow led to a frame-shift to the rest of the VL, 
resulting in novel amino acid sequence with premature termination (*). 
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3.2 MUTAGENESIS 
Mutagenesis was performed by Kunkel method (Kunkel et al., 
1987), mutagenic oligos were designed according to the guidelines of 
Mark J. Zoller (Zoller and Smith, 1989). For each site-directed 
mutation, the mutagenic oligo containing the nucleotide mismatch in the 
middle was annealed to the single stranded, uracil-containing template. 
T4 DNA polymerase was then used to extend the oligo to form a 
complementary circle, with the ends joined together by T4 DNA ligase. 
The heteroduplex was then transformed into a dUTPase+ E.coli strain 
(e.g.TGl)，which would selectively degrade the uracil-containing strand, 
leaving the mutagenic oligo-derived strand as template for replication. 
Mutants were identified by randomly picking the clones and sequencing 
the DNA. In order to increase the number of clones to be sequenced, 
only the substituting base involved in the mutagenesis was sequenced 
initially. Thus, for the insertion of A, all the clones were sequenced for 
only the As (Fig.27a). The same strategy in principle applied to 3 other 
base substitutions, S(40)P:TCT-^CCT (Fig. 27b), G(49)A:GGT-^GCT 
(Tig. 23c), all involving substitution by C. The VH gene fragments with 
the base substitutions were used to replace the original VH through the 
Hindlll and Sad sites in the construct, of which the VL reading frame 
had been restored. Afterward, the complete sequences of the mutants 
were authenticated by autosequencing. 
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T G C A * * 
2 7 5 2 R ： ： 普 攀 ‘ M L M ^ . 
_：議 
會 • 攀 專 _ 
2772 • 霧 
• H ^ B 
• m 
2 7 8 1 : • I H ^ ^ ^ ^ ^ H I 
VL sequence before correction 
2 7 5 2 2 7 7 2 . 2 7 8 1 
5"" ATCGAGCTCA CTCAGTCTCC AATCCTGTCA 3， 
After correction 
S-" A 3--
Figure 27a D N A sequencing result showing addition of A at position 2772 for the 
correction of the light chain reading frame. 
Left panel, D N A sequence in all 4 bases from position 2752 to 2781 
of the VL in Mab2-scFv before correction of reading frame. 
Numbering of nucleotide of 4 lanes position according to the sequence 
of p C A N T A B - 5 E Mab2 in Table 4. 
Right panel, D N A sequence in nucleotide A only of the randomly 
picked clones after mutagenesis for correcting the reading frame. The 
2 clones with the corrected reading frame by inserting of a nucleotide 
A at position 2772 are indicated by asterisk. The A insertion is 
indicated by the arrow. 
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A C G T A C G T 
2 4 7 8 ^ 
^ M g M U l 
‘ ^ ^ ^ ^ ^ ^ ^ ^ 
^ ^ ^^ .. 
V P g m ^^ ^ n p 
J m - J 
^ ^ ^ P .^tmm^ V H P 
2 4 2 7 — ^ FLPI _ I H R 
VH wild-type sequence 
2427 2452 
5'TTTCTACATG GAGTGGGTCC GCCAGTCTCC AGGGAAGAGA 
mutated c T 
sequence 
2478 
CTGGAGT6GA TT 3， 
Figure 27b D N A sequencing result showing substitution of T by C at nucleotide 
position 2452 to generate S(40H)P mutation. 
Left panel of 4 lanes, D N A sequence in all 4 bases from position 2427 
to 2478 of the wild-type VH in Mab2-scFv. The nucleotide numbering 
system is same as that in Fig. 27a. 
Right panel of 4 lanes, D N A sequence in all 4 bases of the positive 
clone from nucleotide C screening of the randomly picked clones after 
mutagenesis for changing the nucleotide T at position 2452 to C. The 
mutation to C is indicated by the arrow. 
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A C G T * * 
mgUi^ . ^ f^^p^� ,伊； j j^^B^ ‘ 
^ ^ . H P 
• . 霧 . 
_ 響 • 
雄 
霸 
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S B ' 
^ •— 
, ... 
Figure 23c D N A sequencing result showing substitution of G by C at nucleotide 
position 2480 to generate G(49H)A mutation. 
Left panel of 4 lanes, D N A sequence in all 4 bases of the wild-type 
in Mab2-scFv. The nucleotide numbering system is same as that in 
Fig.27a. 
Right panel, D N A sequence in nucleotide C only of the randomly 
picked clones after mutagenesis for changing the nucleotide G in 
position 2480 to C. The correctly mutagenized clones are indicated 
by the astrisk. The mutation to C is indicated by the arrow. 
} 
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3.3 EXPRESSION AND CHARACTERIZATION OF WILD-
TYPE scFv 
3.3.1 ScFv soluble protein 
Expression of the soluble protein was revealed by SDS-PAGE. 
The periplasmic extract of bacteria host (HB2151) infected by the 
recombinant phage or its mutagenized derivatives were analyzed in both 
denaturing and non-denaturing 12% SDS-PAGE. A recombinant scFv 
protein band of 32kD was observed with all the recombinant and mutant 
clones, but not with the uninfected host. Fig. 28 shows the typical result 
of one of the clones. The size of the scFv was consistent with the 
molecular weight predicted from the amino acid sequence. Native scFv 
revealed the similar size as the denatured one, as the intra-domain 
disulfide binds have little influence on the mobility of protein in the SDS 
gel. Presence of scFv in the periplasmic extract was double checked by 
ELISA, starting at the protein concentration of 52 mg ml'^ Peroxidase 
conjugated anti-E-tag antibody was used as the detecting reagent. 
Periplasmic extract of uninfected bacteria host was the negative control. 
As shown in Fig. 29, the anti-E-tag antibody could only unambiguously 
detect the scFv at concentrations higher than 5 mg ml'^  (approximately at 
10-fold dilution). The low sensitivity of the anti-E-tag antibody 
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1 10 100 1000 
periplasmic extract dilution 
Figure 29 Detection of the E-tag bearing scFv using peroxidase conjugate anti-
E-tag antibody by ELISA. Both the periplasmic extracts of the 
recombinant phage infected (•) and uninfected HB2151 host p ) were 
prepared using the same condition. 
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3.3.2 Phage-displayed scFv 
Wild type scFv with the L chain reading frame corrected were 
expressed on the bacteriophage, uniformity in culture conditions were 
maintained for each experiment and throughout the project. Phage 
particle numbers were determined by counting the colony forming units 
which were in the order of lO^ to phage per milliliter in the crude 
culture supernatant. All the phages were concentrated by PEG 
precipitation to around phage per milliliter and then re-suspended in 
PBS before assaying for antigen-binding activity. Enzyme linked anti-
M13 antibody was used as detecting reagent in all the binding assay 
using scFv bearing phage particles. 
3.3.3 Standardization of PC antigens 
The phage-displayed scFv was used to bind PC antigen 
presented in 3 different formats: the PC presented by TsAg, conjugated 
to carbohydrate as in Pneumovax® 23 (PnX), and to a protein carrier, 
human serum albumin (HSA). The PC antigens were titrated by the Ts2 
antibody, which binds to PC in all the 3 format using ELISA (Fig. 30). 
Using Ts2 antibody at 0.83mg ml], and at the absorbance OD490皿 of 0.9, 
the coating dilution of TsAg, affinity purified TsAg (pTsAg), PnX and 
PC-HSA were determined as 4000 (2mg/ml protein stock), 125 
(100|ig/ml protein stock); 800 (50|ig/ml carbohydrate stock) and 400 
(lOmg/ml protein stock), respectively. Assuming the Ts2 antibody has 
equal binding affinity to the PC-antigens in all the 3 formats, then the PC 
molecules coated on each well at 00490^^ at 0.9 would be 3.305x10^^ 
irrespective of the forms of the PC antigens, using PC-HSA as standard 
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(molar ratio of PC to HSA being 7). The same coating dilutions of the 
PC antigens as above were to be used in all the subsequent ELISA for 
studying the binding activity of scFv, either in phage or soluble form, in 
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Antigen coating dilution 
Figure 30 Titration of phosphorylcholine (PC)-antigens by Ts2 antibody at the 
final antibody concentration of 0.83mg/mL 
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3.3.4 Binding activity of scFv 
For the binding activity of the wild type scFv phage, the 
ELISA results are shown in Fig. 31, which indicates that unlike Mab2 
antibody that binds PC with carrier specificity, the phage scFv can bind 
equally well to all PC tested regardless of the carrier. Negative controls 
were the LPS (containing no PC), and Ml3 phage without scFv. 
Surprisingly, the phage-displayed scFv shows very high sensitivity in 
ELISA, compared to the parent Mab2 antibody. The binding of phage-
scFv can be detected down to lO'^ M whereas Ts2 antibody and Mab2 
antibody need 10- to 100- fold higher concentration, respectively, to 
become detectable. 
As the copy number of scFv expressed per phage particle can 
range from 1 to 5, this variation may affect the binding avidity. 
Therefore, the effect of change on avidity on carrier specificity was 
studied using the Fab fragment of Mab2. 
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1.0 - r 
0.8 - t A O — • ~ TsAg 
J t ^ ~ 0 ~ pTsAg 
E 0.6 - jfflHpi ^ ― 隨 
g y ~ • ~ PC-HSA 
I�.4 ； W — LPS 
O�.2 ； g f e ^ — I P 一 
0 , 0 I I I 丨“…丨 _ • I I I I I | I 11""， _ 丨"••• 
10_9 10"^ 10_7 10"^ 
p h a g e s c F v ( M ) 
20 1 — 2.0 -1 
b . c 
IS: / IS: > 
•O.s 4-- -0.5 1 - I 
10 -7 10 -6 10 -5 10 4 10 -9 10 "« 10 10 "6 10 "5 
_ (M) Ts2 (M) 
Figure 31 Binding specificity of phage-displayed Mab2-scFv. 
Phage-displayed Mab2-scFv (a), Mab2 parent monoclonal antibody 
(b), and Ts2, a PC binding monoclonal antibody (c) were tested in 
ELISA for binding to PC presented in various formats (see text for 
details). 
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3.3.4.1 Influence of the avidity on carrier specificity binding 
Protein A purified Mab2 antibody was digested by papain for 
16 hours. The duration of digestion had been determined in a pilot 
experiment which showed complete digestion in 15 hour, the extra hour 
was to ascertain completion of the digestion. Fig. 32 shows the SDS-
PAGE analysis of the digestion. As the Fab can bind to protein A, being 
a member of the SI 07 family, protein A could not be used to remove any 
undigested Mab2. The possible presence of the undigested Mab2 was 
therefore tested by ELISA. In the test, serial dilutions of papain treated 
Mab2 antibody was applied to the ELISA plates coated with TsAg. The 
binding activity detected by the goat anti-mouse whole IgG secondary 
antibody was compared with the goat antibody specific to the Fab part of 
mouse IgG. As shown in Fig. 33a, binding of goat anti-mouse whole 
IgG was no longer parallel with that of the anti-mouse IgG Fab antibody. 
Instead, the binding activity of the anti-whole IgG remained at almost 
background level in the dilution range of the papain-treated Mab2, where 
the activity of anti-IgG Fab reached from background to near maximum. 
This indicated that the papain treatment was efficient in digesting almost 
all the Mab2 antibody molecules. 
As shown in Fig. 33b, the papain digested Mab2 antibody (i.e. 
Fab) displayed the same carrier specificity as the whole Mab2 antibody 
in binding PC antigens. However, the Fab fragment showed 100-fold 
less binding activity than the whole antibody. Together, these results 
show that the carrier specificity of Mab2 is not affected by decrease in 
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Figure 32 Analysis of the papain digestion of M a b 2 antibody on 12% SDS-
P A G E . 
The heavy chain have been completely digested to two fragments of 
25kD (denatured form). 
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Figure 33 Binding activity of the papain digested Mab2 antibody 
(a) The purity of the Mab2 in Fab form (circle) binds on TsAg is 
detected by both peroxidase conjugated goat anti-mouse Ig 
antibody (open) and biotin conjugated goat anti-mouse Fab 
(closed). The intact Mab2 antibody (square) is employed for 
comparison. 
(b) Binding curve of the Mab2 Fab on standardized 
phosphorylcholine containing antigens: TsAg (•); Mab2 
antibody affinity purified TsAg (O); PnX (•) and PC-HSA ( • ) 
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3.4 ANTIGEN SPECIFICITY 
To confirm that the PC hapten is the antigenic specificity of 
the phage scFv, inhibition assay using free PC haptens and inhibition 
assay of scFv to intact Ts2 antibody bindings were performed. 
3.4.1 Free hapten inhibition 
In the free hapten inhibition assay, two forms of free PC were 
employed: phosphorylcholine chloride (PCCl) representing the PC in 
free form, and p-nitrophenylphosphorylcholine (NPPC) mimicing the 
PC-carbohydrate conjugate structure. The free haptens starting from 10" 
^M were used to inhibit binding of the phage scFv (10.0 nM) to TsAg. 
The same parallel experiments were done with Mab2 whole antibody 
(5.0 |iM), Ts2 (70nM) and Mab2 Fab (800|iM). To control for the 
possible effect in binding due to the wide range of changes in the salt 
concentration caused by the haptens, corresponding amounts of NaCl 
were added in place of the haptens in the binding control (no inhibitor). 
As shown in Fig. 34, both the intact Mab2 and Ts2 antibodies were 
completely inhibited by either PCCl or NPPC at 10'^  M as previously 
reported before (Lim et al, 1994). On the other hand, the inhibition on 
Mab2 Fab was 60% at 10'^  M of the haptens. This discrepancy with the 
whole antibodies could be due to a thousand-fold difference in the 
concentration of the Mab2 Fab used in the ELISA. However, no 
inhibition was shown on the phage scFv binding to TsAg by the hapten. 
As a positive inhibition control, TsAg could inhibit the binding of the 
scFv to the immobilized TsAg by 55%. Thus, the phage scFv binds 
specifically to a component in TsAg. As the above inhibition result 
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appeared to contradict the direct binding assay described in 3.3.3 that 
showed PC-binding activity of the scFv regardless of the carrier, the 
issue of whether or not PC was the phage scFv binding component on 
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Figure 34 Binding inhibition assay using P C haptens (PCCl and NPPC). 
Binding of phage-displayed scFv (lO.OnM) (a), Mab2 whole antibody 
(5.0IJ.M) (b), Mab2-Fab (SOO^M) (c), and Ts2 (70nM) (d) to 
immobilized TsAg in ELISA in the presence of PC haptens, PCCl and 
NPPC, in serial dilution. 
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3.4.2 Inhibition on the binding of Ts2 
scFv expressed in both phage-displayed and soluble protein 
forms were used to inhibit the binding of Ts2 antibody to TsAg, PnX 
and PC-HSA. The concentration of Ts2 antibody used in this assay was 
the same as that on the previous inhibition assay (section 3.4.1), in which 
the free hapten could completely block the binding. As shown in Fig. 35, 
the scFv in both forms could achieve up to 50% inhibition. Based on the 
well established PC hapten specificity of Ts2，the above results indicate 
that the scFv in both phage-display and soluble forms should bind 
specifically to the PC hapten. This PC-binding specificity cannot be 
attributed to some unexpected nature particular to phage particle, as the 
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Figure 35 Inhibition of Ts2 antibody binding to PC by scFv. Binding of Ts2 
antibody to immobilized TsAg in ELISA in the presence of serial 
dilution of a) phage-displayed Mab2-scFv (•), and b) soluble Mab2 
scFv(#). Open circle (〇）denotes parent Ml3 phage in a), and 
uninfected host lysate in b) as negative inhibition controls. Open 
square (p) in b)，c), d) and e) denotes the TsAg specific, but non-PC 
binding antibody 7C2C5 as another negative inhibition control. 
Binding of Ts2 antibody to c) pTsAg, d) PnX and e) PC-HSA in the 
presence of serial dilution of soluble scFv. 
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3.4.3 Binding affinity 
The affinities of Mab2-scFv and the parent Mab2 antibody to 
NPPC, a derivative of PC which was previously shown to have a higher 
affinity to Mab2 with PCCl (section 3.4.1), were measured by 
fluorescence quenching. Soluble form of scFv was used for its known 
valency of 1, and availability in higher yield compared with the phage-
display form. Fluorescence quenching due to binding of the hapten was 
normalized and calculated using the logarithmic form of the Sips 
distribution function. From the Sips plot (Fig. 36), the affinity constant 
determined for Mab2 was 6.59xlO^M"^ and that for scFv was 3.51xlO^M' 
1. This result further confirmed the PC-binding specificity of scFv. 
However, the binding affinity of Mab2-scFv showed a 2-fold decrease 
compared with the parent Mab2 whole antibody. By comparing the 
heterogeneity index (a) of Mab2 and that of the scFv, it appears that the 
PC-binding pockets of the 2 antibody forms have different 
conformations. Thus, it is plausible that this change in the conformation 
of binding pocket from the form in the Mab2 antibody to that in the scFv 
leads to the decrease in PC-binding affinity. 
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1 2 3 4 
log c ( \ j M ) 
• M a b 2 y = - 1 . 9 3 2 0 + 0 .60733x = 0 .965 
K=6.59x10®M^ 
• S c F v y = - 4 .6890 + 1.3575x RA2 = 0 .989 
K=3.51x105M1 
Affinity constant was calculated by the Sips equation: 
log r/n-r = a log K + a log c 
where, r = ratio of antibody bind with hapten; 
c = free hapten concentration 
n = number of binding site per molecule 
K = average intrinsic association constant (affinity) 
a = heterogeneity index 
when all binding sites are occupied, r/n-r = 1; log r/n-r = 0 
Ko=l/c 
Figure 36 Sips plot of the fluorescence quenching for both Mab2 and scFv. 
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3.5 BINDING ACTIVITIES OF THE MUTANTS 
Binding activities of different phage scFv mutants to PC 
antigens in different formats were compared with the phage-display wild 
type by ELISA (Fig. 37). All the mutants were found to bind to the PC 
antigens in a profile similar to the wild type, without showing the carrier 
specificity to TsAg as parental Mab2 antibody does. This result was 
confirmed in the subsequent inhibition assay in Ts2 antibody binding to 
PC antigens (Fig. 38). 
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Figure 37 Binding activities of the wild type and mutant phages against PC-
antigens. (Data shown represent the means of triplicates) The phage 
particle number was standardized at 3.0x10^^ /ml. LPS is used as 
control antigen. 
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Figure 38 Binding inhibition of Ts2 antibody to PC antigens by soluble scFv. 
The immobilized PC antigens for binding of Ts2 antibody in ELISA 
in the presence of soluble Mab2-scFv were TsAg, PnX and PC-HSA. 
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CHAPTER 4 GENERAL DISCUSSION 
The antibody combining site is determined by the Fv region of the 
molecule, formed by the variable domains (VH and VL) of the heavy and 
light chains. Since 1988，it has been possible to produce recombinant Fv 
fragments with antibody activities in bacteria, initially as proteins 
assembled noncovalently from individual VH and VL polypeptides, and 
subsequently and more popularly, as a single-chain product (scFv) in 
which the V^ and VL segments are joined together by a synthetic linker 
(reviewed by G. Winter)(Winter et aL, 1994). The linker most 
commonly used is a long and highly flexible peptide [(glyjSer)]] which 
permits refolding and association of the segments. The scFv fragment 
can be produced either as a phage-displayed protein or as a soluble 
monomer. Many different scFvs of various specificities have been 
produced over the years, many of which have found diagnostic 
applications both in vitro and in vivo (Begent et al., 1996), while others 
have shown potential as therapeutic agents (Huls et al., 1999). 
The fidelity of scFvs, that is, whether the combining site of these 
proteins is a bona fide replica of that of native antibodies, is often taken 
for granted because scFvs are known with similar structural properties as 
the native molecule (Pantoliano et al., 1991) (Jager and Pluckthun, 
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1999a), and，more importantly, useful and high-affinity scFvs are 
continually found. However, since these proteins are usually isolated 
from combinatorial libraries comprising V^ and VL segments derived 
from various sources and hence are highly selected for their binding, this 
does not address the issue directly, A more critical examination requires 
the direct comparison between a native antibody (hybridoma-derived, for 
example) and its scFv derivative. There are not many studies of this 
kind，and where this was done, the parameter most commonly assessed is 
one of function, the affinity of the protein. In this regard，there are 
conflicting reports (Abraham et al., 1995; Glockshuber et al., 1990; 
Pantoliano et al, 1991; Verhaar et al., 1995). Of particular note is the 
study by Abraham et al (1995), who constructed various antibody 
fragments of an IgG hybridoma antibody to carcinoembryonic antigen 
(CEA). The binding efficiencies of these derivatives bound well to the 
antigen all at very similar rates as the native antibody, they, however, 
dissociated much faster from the antigen: the scFv fragment by 200 
times, and the Fab, which is also univalent like scFv but contains 
additional domains (Fd) of the heavy and light chains, by about 90 times. 
Increasing the valency of the scFv in the form of diabodies (dimers) 
increased the stability substantially, but even these dissociated 10-times 
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faster than the native antibody, suggesting other attributes of the protein 
may be important for proper binding. 
An aspect of antibody fonction that has not been addressed in 
scFvs is the carrier specificity, a feature known in some native antibodies 
(Brown et al, 1999), A hybridoma antibody (Mab2) was recently 
described from our laboratory which recognizes the PC hapten only 
when this is presented in the form of the antigen used originally in the 
induction of the antibody (Lim et al.’ 1994b). It does not bind to other 
PC-associated antigens and is thus unique among PC-binding antibodies. 
It belongs to the M511 family of PC-binding antibodies, the other 
families being TI5 and M603, which are distinguished from one another 
by their light chains. 
In this study, I have constructed a scFv based on the Mab2 VH and 
VL sequence and found this derivative to be slightly different from the 
parental antibody. Thus, the and V^ genes ofMab2 were cloned into 
the pCANTAB-5E phagemid expression vector and scFvs were obtained 
both as a 32kD soluble protein or as a phage-displayed antibody. 
Considerable time was spent in checking that the scFv was correctly 
constructed using restriction-enzyme mapping and sequencing of the Ig 
genes. A reading frame-shift found in the VL segment initially was 
corrected by inserting an adenine between the linker and V^. 
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Binding studies of phage-displayed scFv fragment, performed 
using ELISA，showed that, surprisingly, this protein bound 
indiscriminately to all the PC-antigens examined, mcluding TsAg (crude 
or Mab2 affinity purified), PnX and PC-HSA. This is different from the 
parental antibody, which binds TsAg preferentially. In other words，in 
the scFv form，there is no carrier specificity. The lack of preferential 
binding to TsAg by the Mab2 scFv protein was also observed for the 
soluble scFv fragment in studies which showed that the scFv fragment 
inhibited the binding of the Ts2 hybridoma antibody regardless of the 
target PC-associated antigen. 
The lack of carrier specificity in the Mab2 scFv protein suggests 
that the combining site of the molecule may lack the ordered structure 
present in the hybridoma antibody. The combining site of the hybridoma 
protein is presumably similar to that of the PC-binding myeloma protein, 
M603 (of the M603 family)，in which x-ray crystallographic studies 
revealed the presence of an inner pocket formed by VH and VL (Satow et 
al, 1986), The choline moiety of PC fits well to this pocket and 
interacts with V^ residues such as giutamate at positions ¥^35 and ¥^58. 
The phosphate group in PC interacts with V^ and V^ segments further 
out from the pocket while the carrier residues of the ligand are 
presumably accommodated by the outer regions of the cavity. It seems 
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that for most PC-binding antibodies，the carrier-deteTmining region has a 
large degree of flexibility to accommodate all types of structures，and the 
antibody binds to the antigen in an 'induced fit，manner. The Mab2 
hybridoma antibody，on the other hand, is somehow restricted 
structurally in this regard. It seems to have a preformed combining site 
and binds the antigen in a 'Iock-and-key' mode (Wedemayer et al, 
1997). However, reassembling the V^ and segments in the form of a 
scFv protein destroys this preformed structure. It is possible that, in the 
Mab2 scFv (or other scFv fragments), the combining site is less stably 
formed than in the native molecule and exist in a dynamic flux，thus 
obviating any physical restraint of the molecule and allowing antigens of 
diverse structure to enter the binding site. The flux may be due to the 
greater mobility of the VH and V^ segments, in whole (regardless of the 
conformational flexibility within each segment) or in parts of these，than 
would be the case in the native antibody. This, m turn，may be due to the 
high mobility of the linker peptide [(gly^sery used to bridge the 
segments, known to be true of the M603 fragment (Freund et al, 1994), 
Conceivably, antigen can provide a stabilizing force to scFvs such as the 
Mab2 derivative, as it does for the M603 Fv fragment (Jager and 
Pluckthun, 1999b). Although this does not constitute proof that the scFv 
combining-site is not exactly the same as that of the native protein，it is 
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noteworthy that the process involved in the formation of the site is 
slightly different between the two types of protein. Thus, Jager and 
Pluckthun (1999) found that whereas the Fv fragment composed of 
native V^ and V^ chains, refolded in a direct and fast mmmer, refolding 
of the scFv molecule was characterized by the formation of an 
intermediate, in which the V^ and V^ segments associated prematurely, 
presumably forced upon by the linker. Whether linkers of greater 
lengths (Desplancq et al, 1994; Whitlow et al.’ 1993) or of a different 
composition (Stemmer et al, 1993)，known to increase the affinity of the 
scFv, can enhance the specificity of the protein is an interesting and 
important question. Equally as intriguing is whether seFv multimers (Le 
Gall et al, 1999), in which the linker plays no role in forming the 
combining site, have greater fidelities than the monomers. 
The loss of carrier specificity in the Mab2 scFv may also result 
from a distortion in the formation of the heavy chain. In the native 
antibody, the presence of certain amino add residues in the heavy chain， 
particularly glycine at position H49 (which is alanine in all other known 
PC-binding antibodies), may be responsible for the structural restraint 
associated with carrier specificity (Lim et al, 1994b). In this connection, 
it is interesting to note that in a related PC-binding antibody, T15, Brown 
et al (1999) found several residues located at CDR2 (Complementarity 
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Determining Region) in this protein, particularly asparagine (H53), 
which were important for carrier recognition (Brown et al, 1999). It is 
possible that in our protein, the structural restriction present may be 
dependent on other domains m the heavy chain which are absent in scFv, 
such as C^I or or polysaccharides which can only be incorporated 
in eiikaryotic expression systems. Alternatively, the type of 
conformation seen in the native polypeptide chain somehow requires the 
work of a mammalian protein folding machineiy (Jost et al, 1994). 
Consistent with the view that the Mab2 scFv fragment has a less-
ordered structure than the parental antibody is the results of the hapten 
inhibition assay. Unlike the parental antibody m whieh the free PC 
hapten (lO"^  M) or an analogue of PC (nitrophenyl-PC, 10"^  M) was 
found to abolish virtually all antibody activity, the phage-associated seFv 
protein was not sensitive to inhibition by these compounds. Specificity 
of binding of the scFv protein to TsAg，however, was ascertained from 
the ability of the pratdn to inhibit the binding of the Ts2 hybridoma-
derived antibody to this antigen. The fact that the haptens, PC and 
nitrophenyl-PC, do not block the binding activity of the scFv protein 
implies that the scFv combining site may be so loose that a defined PC-
accommodating pocket may not exist. A likely reason for the lack of 
inhibition seen is that the scFv fragment binds better to the multivalent 
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native antigen than to the haptens. This, presumably, is due to its own 
multivalency in the form of a phage-displayed protein (each virion 
having up to 4 copies of scFv) and, secondly, the additional interaction 
with carrier residues in the native antigen. In direct binding studies, the 
scFv soluble fragment was shown to bind to the free PC hapten with an 
affinity of 3,5 x iO^M'^  half that of the parental antibody. 
The original objective of investigating whether the glycine (VH49) 
or serine (VH40) residue contribute to the carrier specificity of Mab2 
cannot be addressed in the scFv model for the reasons discussed above. 
However, since we had already constructed the giycine-to-aianine (¥^49) 
. • - . • • • • 
and serine-to-proline (¥^40) seFv mutants using site-directed 
mutagenesis (Kunkei et al., 1987) prior to knowing the characteristics of 
the Mab2 scFv protein, the binding activities of these proteins were 
nevertheless examined, Expeetedly, like the wild type scFv protein, both 
showed comparable binding to all the antigens used (TsAg, PnX and PC-
HSA), thus lacking carrier specificity, and both could speeifieaily inhibit 
the binding of the Ts2 iiybrid0nia antibodies to TsAg. The PC binding 
property retained in these two mutants, same as in the wild type, 
suggests that although these two amino-acids in Mab2 do not contribute 
to hapten binding, they may still be responsible for the earner restriction. 
Indeed, a recent study indicates that the proline-to-alanine substitution at 
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V H 4 0 of the M603 scFv protein can confer stability to the protein 
(Knappik and Plukthun, 1995). 
If the importance of the V H 4 0 and VH49 residues are to be 
addressed in fiiture studies, it may first be necessary to modify the 
construction of scFv proteins so that they have the same combining-site 
structure and specificity as conventional antibodies. One possibility, as 
discussed above, is to use a more appropriate linker. Adding a disulfide 
linkage between VH and V^ may confer not only stability to the protein 
(Brinkmann et al., 1993) but, perhaps also, a more ordered structure. In 
this regard, Fab fragments (Orfanoudakis et al., 1993; Skerra and 
Pluckthun, 1991), formed by the pairing of the whole light chain and the 
first two domains of the heavy chain, may have certain advantages over 
scFy fragments. Altemativeiy, it may be best to study the mutations in 
Mab2 using whole Ig molecules expressed in a mammalian expression 
system. This may be done by reconstructing the V^ and V^ genes of the 
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